Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	GPHN TPR ABI3BP MAP1B MAP2 MAP4 APC2 SHROOM2 ALMS1 TTLL2 PIP SVIL GOLGA8B MACF1 PLEC EPB41L2 FRMD3	5.74e-05	1099	105	17	GO:0008092
GeneOntologyMolecularFunction	structural molecule activity	TPR COL5A1 MYOM1 ABI3BP MAP1B MAP2 MAP4 LAMA3 AHNAK VCAN MACF1 PLEC TNXB EPB41L2	2.35e-04	891	105	14	GO:0005198
GeneOntologyMolecularFunction	cytoskeletal regulatory protein binding	MAP1B MAP2	2.71e-04	5	105	2	GO:0005519
GeneOntologyMolecularFunction	tubulin binding	TPR MAP1B MAP2 MAP4 APC2 ALMS1 TTLL2 GOLGA8B MACF1	4.30e-04	428	105	9	GO:0015631
GeneOntologyMolecularFunction	beta-catenin binding	APC2 SHROOM2 CDH8 CDH10 CDH12	4.31e-04	120	105	5	GO:0008013
GeneOntologyBiologicalProcess	supramolecular fiber organization	COL5A1 KLHL24 MYOM1 MAP1B MAP2 MAP4 APC2 SHROOM2 WASHC2A USP8 ALMS1 SVIL PAK3 GOLGA8B PLEC TNXB DYNC1H1 FOXC2	1.72e-06	957	106	18	GO:0097435
GeneOntologyBiologicalProcess	protein localization to site of double-strand break	PARP3 TOPBP1 TP53BP1	7.04e-05	16	106	3	GO:1990166
GeneOntologyBiologicalProcess	regulation of supramolecular fiber organization	MAP1B MAP2 APC2 SHROOM2 WASHC2A USP8 ALMS1 SVIL PAK3 TNXB	8.72e-05	438	106	10	GO:1902903
GeneOntologyBiologicalProcess	negative regulation of protein depolymerization	MAP1B MAP2 APC2 SHROOM2 SVIL	9.61e-05	89	106	5	GO:1901880
GeneOntologyBiologicalProcess	microtubule-based process	TPR CACNA1E ATRX MAP1B MAP2 MAP4 PARP3 APC2 ASH1L RHOT2 ALMS1 TTLL2 GOLGA8B MACF1 DYNC1H1 SON	9.75e-05	1058	106	16	GO:0007017
GeneOntologyBiologicalProcess	cell morphogenesis	ABI3BP MAP1B MAP2 FAT3 LAMA3 ZFPM1 SHROOM2 ITPR1 LIFR PAK3 GOLGA8B MACF1 PLEC CDH8 CDH10 CDH12 EPB41L2	1.20e-04	1194	106	17	GO:0000902
GeneOntologyBiologicalProcess	regulation of microtubule-based process	TPR MAP1B MAP2 PARP3 APC2 ALMS1 MACF1 DYNC1H1	1.36e-04	293	106	8	GO:0032886
GeneOntologyCellularComponent	costamere	AHNAK SVIL PLEC AHNAK2	4.26e-06	22	106	4	GO:0043034
GeneOntologyCellularComponent	postsynaptic specialization	GPHN ABI3BP MAP1B MAP2 MAP4 RTN3 ITPR1 USP8 PAK3 MACF1 NR3C2 CDH10	9.36e-06	503	106	12	GO:0099572
GeneOntologyCellularComponent	postsynaptic density	GPHN ABI3BP MAP1B MAP2 MAP4 RTN3 ITPR1 USP8 PAK3 MACF1 NR3C2	1.84e-05	451	106	11	GO:0014069
GeneOntologyCellularComponent	catenin complex	APC2 CDH8 CDH10 CDH12	2.01e-05	32	106	4	GO:0016342
GeneOntologyCellularComponent	asymmetric synapse	GPHN ABI3BP MAP1B MAP2 MAP4 RTN3 ITPR1 USP8 PAK3 MACF1 NR3C2	3.08e-05	477	106	11	GO:0032279
GeneOntologyCellularComponent	neuron to neuron synapse	GPHN ABI3BP MAP1B MAP2 MAP4 RTN3 ITPR1 USP8 PAK3 MACF1 NR3C2	7.06e-05	523	106	11	GO:0098984
GeneOntologyCellularComponent	postsynapse	GPHN CACNA1E ABI3BP MAP1B MAP2 MAP4 APC2 RTN3 ITPR1 USP8 EIF4G1 PAK3 MACF1 NR3C2 CDH10	1.89e-04	1018	106	15	GO:0098794
GeneOntologyCellularComponent	nuclear body	TCF12 EP400 ATRX RPN2 PARP3 TOPBP1 PAPOLG CDC40 YLPM1 TOPORS TP53BP1 SON FOXC2	6.49e-04	903	106	13	GO:0016604
GeneOntologyCellularComponent	extrinsic component of plasma membrane	GPHN APC2 CDH8 CDH10 CDH12	6.70e-04	137	106	5	GO:0019897
GeneOntologyCellularComponent	adherens junction	KLHL24 LAMA3 SHROOM2 CDH8 CDH10 CDH12	7.45e-04	212	106	6	GO:0005912
GeneOntologyCellularComponent	platelet dense tubular network membrane	IRAG1 ITPR1	8.96e-04	9	106	2	GO:0031095
GeneOntologyCellularComponent	basal dendrite	MAP1B MAP2	1.12e-03	10	106	2	GO:0097441
GeneOntologyCellularComponent	anchoring junction	KLHL24 ASH1L LAMA3 SHROOM2 ARHGAP31 AHNAK CSPG4 SVIL PLEC CDH8 CDH10 CDH12 EPB41L2	1.32e-03	976	106	13	GO:0070161
GeneOntologyCellularComponent	hemidesmosome	LAMA3 PLEC	1.36e-03	11	106	2	GO:0030056
GeneOntologyCellularComponent	platelet dense tubular network	IRAG1 ITPR1	1.36e-03	11	106	2	GO:0031094
GeneOntologyCellularComponent	microtubule associated complex	TPR MAP1B MAP2 MAP4 DYNC1H1	1.38e-03	161	106	5	GO:0005875
GeneOntologyCellularComponent	GABA-ergic synapse	GPHN CACNA1E ITPR1 NR3C2 CDH10	1.50e-03	164	106	5	GO:0098982
GeneOntologyCellularComponent	microtubule	MAP1B MAP2 MAP4 APC2 SHROOM2 SVIL GOLGA8B MACF1 DYNC1H1	1.57e-03	533	106	9	GO:0005874
GeneOntologyCellularComponent	supramolecular fiber	COL5A1 MYOM1 MAP1B MAP2 MAP4 APC2 SHROOM2 AHNAK SVIL GOLGA8B MACF1 PLEC DYNC1H1 AHNAK2	2.51e-03	1179	106	14	GO:0099512
GeneOntologyCellularComponent	actin cytoskeleton	ACACA MAP2 APC2 TOPBP1 SHROOM2 AHNAK SVIL MACF1 EPB41L2	2.64e-03	576	106	9	GO:0015629
GeneOntologyCellularComponent	supramolecular polymer	COL5A1 MYOM1 MAP1B MAP2 MAP4 APC2 SHROOM2 AHNAK SVIL GOLGA8B MACF1 PLEC DYNC1H1 AHNAK2	2.67e-03	1187	106	14	GO:0099081
HumanPheno	Aplasia/Hypoplasia of the skin	COL5A1 KLHL24 ATRX MAP1B LAMA3 LIFR USP8 ARHGAP31 PLEC TNXB	5.61e-06	201	44	10	HP:0008065
HumanPheno	Dermal atrophy	COL5A1 KLHL24 ATRX LAMA3 USP8 PLEC TNXB	2.99e-05	107	44	7	HP:0004334
Domain	LAM_G_DOMAIN	COL5A1 FAT3 LAMA3 CSPG4	6.01e-05	38	105	4	PS50025
Domain	Laminin_G_2	COL5A1 FAT3 LAMA3 CSPG4	7.38e-05	40	105	4	PF02210
Domain	TAU_MAP_2	MAP2 MAP4	9.36e-05	3	105	2	PS51491
Domain	Tubulin-binding	MAP2 MAP4	9.36e-05	3	105	2	PF00418
Domain	MAP_tubulin-bd_rpt	MAP2 MAP4	9.36e-05	3	105	2	IPR001084
Domain	TAU_MAP_1	MAP2 MAP4	9.36e-05	3	105	2	PS00229
Domain	MAP2/MAP4/Tau	MAP2 MAP4	9.36e-05	3	105	2	IPR027324
Domain	LamG	COL5A1 FAT3 LAMA3 CSPG4	1.08e-04	44	105	4	SM00282
Domain	Laminin_G	COL5A1 FAT3 LAMA3 CSPG4	3.17e-04	58	105	4	IPR001791
Domain	Cadherin_C	CDH8 CDH10 CDH12	3.63e-04	25	105	3	PF01049
Domain	Cadherin_cytoplasmic-dom	CDH8 CDH10 CDH12	3.63e-04	25	105	3	IPR000233
Domain	Cadherin_CS	FAT3 PCDH11X CDH8 CDH10 CDH12	3.75e-04	109	105	5	IPR020894
Domain	CADHERIN_1	FAT3 PCDH11X CDH8 CDH10 CDH12	4.43e-04	113	105	5	PS00232
Domain	Cadherin	FAT3 PCDH11X CDH8 CDH10 CDH12	4.43e-04	113	105	5	PF00028
Domain	AT_hook	ASH1L AHDC1 ZNF653	4.58e-04	27	105	3	SM00384
Domain	AT_hook_DNA-bd_motif	ASH1L AHDC1 ZNF653	4.58e-04	27	105	3	IPR017956
Domain	CADHERIN_2	FAT3 PCDH11X CDH8 CDH10 CDH12	4.61e-04	114	105	5	PS50268
Domain	-	FAT3 PCDH11X CDH8 CDH10 CDH12	4.61e-04	114	105	5	2.60.40.60
Domain	-	MACF1 PLEC	4.63e-04	6	105	2	3.90.1290.10
Domain	CA	FAT3 PCDH11X CDH8 CDH10 CDH12	4.80e-04	115	105	5	SM00112
Domain	Cadherin-like	FAT3 PCDH11X CDH8 CDH10 CDH12	4.99e-04	116	105	5	IPR015919
Domain	Cadherin	FAT3 PCDH11X CDH8 CDH10 CDH12	5.40e-04	118	105	5	IPR002126
Domain	Catenin_binding_dom	CDH8 CDH10 CDH12	5.67e-04	29	105	3	IPR027397
Domain	-	CDH8 CDH10 CDH12	5.67e-04	29	105	3	4.10.900.10
Domain	FN3	MYOM1 ABI3BP LIFR TIE1 ASTN1 TNXB	6.23e-04	185	105	6	SM00060
Domain	Plectin	MACF1 PLEC	6.45e-04	7	105	2	PF00681
Domain	Plectin_repeat	MACF1 PLEC	6.45e-04	7	105	2	IPR001101
Domain	PLEC	MACF1 PLEC	6.45e-04	7	105	2	SM00250
Domain	ATP_grasp_subdomain_2	ACACA SUCLA2 TTLL2	6.92e-04	31	105	3	IPR013816
Domain	FN3	MYOM1 ABI3BP LIFR TIE1 ASTN1 TNXB	9.11e-04	199	105	6	PS50853
Domain	FN3_dom	MYOM1 ABI3BP LIFR TIE1 ASTN1 TNXB	1.17e-03	209	105	6	IPR003961
Domain	-	COL5A1 FAT3 LAMA3 CSPG4	2.03e-03	95	105	4	2.60.120.200
Domain	EGF	FAT3 LAMA3 TIE1 VCAN ASTN1 TNXB	2.13e-03	235	105	6	SM00181
Domain	fn3	MYOM1 ABI3BP LIFR TIE1 TNXB	2.22e-03	162	105	5	PF00041
Domain	FA	EPB41L2 FRMD3	2.35e-03	13	105	2	PF08736
Domain	FERM-adjacent	EPB41L2 FRMD3	2.35e-03	13	105	2	IPR014847
Domain	FA	EPB41L2 FRMD3	2.35e-03	13	105	2	SM01195
Domain	ATP_GRASP	ACACA SUCLA2	2.73e-03	14	105	2	PS50975
Domain	ATP-grasp	ACACA SUCLA2	2.73e-03	14	105	2	IPR011761
Domain	EGF-like_dom	FAT3 LAMA3 TIE1 VCAN ASTN1 TNXB	2.84e-03	249	105	6	IPR000742
Domain	-	ACACA SUCLA2	3.13e-03	15	105	2	3.30.1490.20
Domain	EGF_1	FAT3 LAMA3 TIE1 VCAN ASTN1 TNXB	3.19e-03	255	105	6	PS00022
Domain	EGF-like_CS	FAT3 LAMA3 TIE1 VCAN ASTN1 TNXB	3.57e-03	261	105	6	IPR013032
Domain	EGF_2	FAT3 LAMA3 TIE1 VCAN ASTN1 TNXB	3.85e-03	265	105	6	PS01186
Domain	ATP_grasp_subdomain_1	ACACA SUCLA2	4.52e-03	18	105	2	IPR013815
Domain	-	ACACA SUCLA2	4.52e-03	18	105	2	3.30.470.20
Domain	BRCT	TOPBP1 TP53BP1	5.03e-03	19	105	2	PF00533
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	ILF3 LAMA3 PLEC CDH8 CDH10 CDH12	6.02e-05	117	82	6	M19248
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	ILF3 PLEC CDH8 CDH10 CDH12	6.49e-05	73	82	5	MM15126
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	ILF3 CDH8 CDH10 CDH12	8.29e-05	40	82	4	MM15060
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	ILF3 CDH8 CDH10 CDH12	1.70e-04	48	82	4	MM15069
Pathway	REACTOME_CELL_CELL_COMMUNICATION	ILF3 PLEC CDH8 CDH10 CDH12	2.38e-04	96	82	5	MM14592
Pathway	REACTOME_CELL_CELL_COMMUNICATION	ILF3 LAMA3 PLEC CDH8 CDH10 CDH12	2.82e-04	155	82	6	M522
Pathway	REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING	LIFR ELF1	3.30e-04	5	82	2	M27800
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	ILF3 CDH8 CDH10 CDH12	3.55e-04	58	82	4	M11980
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR ILF3 ACACA EP400 ATRX MAP4 RALGAPB ZFPM1 EZH2 PAPOLG INTS5 ZC3H11A GTF3C1 MAGED2 SVIL YLPM1 EIF4G1 EIF5B ELF1 PLEC TOPORS DDX21 EPB41L2 TP53BP1 SON	9.88e-19	774	107	25	15302935
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GPHN TPR ILF3 ACACA EP400 ATRX MAP1B MAP4 LDHB TRIP11 KIAA1671 USP8 ZC3H11A ALMS1 AHNAK YLPM1 EIF5B MACF1 DDX21 RSBN1L GOLGB1 EPB41L2 TP53BP1 SON AHNAK2	8.00e-17	934	107	25	33916271
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR COL5A1 ACACA MAP1B MAP4 RPN2 URB1 ZC3H11A GTF3C1 AHNAK YLPM1 EIF4G1 EIF5B MACF1 PLEC DDX21 DYNC1H1 EPB41L2 TP53BP1 SON	1.16e-14	653	107	20	22586326
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ILF3 TCF12 ACACA EP400 MAP1B MAP4 TRIM24 AHDC1 PAPOLG ZC3H11A MAGED2 SBNO1 AHNAK PIP EIF4G1 EPB41L2 AHNAK2	3.80e-14	444	107	17	34795231
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	TPR ILF3 ACACA EP400 MAP1B MAP4 RHOT2 LDHB URB1 ZC3H11A OXCT1 GTF3C1 CDC40 MAGED2 AHNAK PIP EIF4G1 EIF5B MACF1 PLEC DDX21 DYNC1H1 EPB41L2 TP53BP1 SON AHNAK2	4.39e-14	1353	107	26	29467282
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	TPR ILF3 MAP4 RPN2 LAMA3 LDHB KIAA1671 ZC3H11A GTF3C1 CDC40 MAGED2 AHNAK PIP SVIL EIF4G1 EIF5B LRRC8A PLEC TOPORS DDX21 RSBN1L DYNC1H1 EPB41L2	4.41e-12	1257	107	23	36526897
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	TPR ILF3 EP400 MAP1B MAP4 KIAA1671 URB1 ZC3H11A GTF3C1 AHNAK SVIL YLPM1 EIF4G1 EIF5B MACF1 PLEC DDX21 DYNC1H1 GOLGB1 EPB41L2 SON	5.20e-12	1024	107	21	24711643
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GPHN ACACA MAP1B MAP2 MAP4 RALGAPB TRIP11 KIAA1671 USP8 ALMS1 AHNAK SVIL EIF4G1 MACF1 NR3C2 PLEC GOLGB1 EPB41L2 AHNAK2	1.75e-11	861	107	19	36931259
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCA2 ACACA EP400 TMCO6 RHOT2 ZFPM1 WASHC2A AHDC1 PCNX2 URB1 INTS5 ZC3H11A SH3TC1 AHNAK CSPG4 EIF4G1 C19orf44 PLEC BCL2L13 DYNC1H1 AHNAK2	2.15e-11	1105	107	21	35748872
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	TPR TRIP11 LPIN1 MAGED2 AHNAK SVIL EIF4G1 MACF1 PLEC DYNC1H1 GOLGB1 TP53BP1 AHNAK2	9.53e-11	360	107	13	33111431
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ILF3 EP400 MAP1B MAP2 RPN2 LDHB AHDC1 INTS5 GTF3C1 CDC40 VCAN YLPM1 EIF4G1 EIF5B MACF1 PLEC DDX21 TNXB DYNC1H1 SON	1.12e-10	1082	107	20	38697112
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GPHN TPR ACACA EP400 MAP1B MAP4 KIAA1671 ZC3H11A GTF3C1 ALMS1 AHNAK YLPM1 RSBN1L DYNC1H1 TP53BP1	1.55e-10	549	107	15	38280479
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GPHN TPR ACACA MAP1B MAP2 MAP4 RTN3 SUCLA2 SHROOM2 WASHC2A LDHB ITPR1 OXCT1 TCF25 PAK3 MACF1 ASTN1 PLEC EPB41L2 TP53BP1	2.74e-10	1139	107	20	36417873
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	KLHL24 AHDC1 FAM78A ZC3H11A AHNAK SVIL EIF4G1 MACF1 PLEC DYNC1H1 SON AHNAK2	5.18e-10	332	107	12	37433992
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	TPR EP400 ATRX MAP4 ZC3H11A GTF3C1 AHNAK EIF4G1 PLEC DYNC1H1 TP53BP1 AHNAK2	5.18e-10	332	107	12	32786267
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	GPHN TPR ILF3 MAP4 TOPBP1 EZH2 ZC3H11A GTF3C1 EIF4G1 EIF5B ELF1 EPB41L2 TP53BP1 SON	5.22e-10	503	107	14	16964243
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TPR ILF3 EP400 ATRX MAP1B MAP4 TOPBP1 TRIM24 LDHB ZC3H11A AHNAK YLPM1 EIF4G1 EIF5B DDX21 RSBN1L TP53BP1 SON	7.73e-10	954	107	18	36373674
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ILF3 ACACA MAP1B MAP4 RPN2 WASHC2A URB1 AHNAK YLPM1 EIF4G1 EIF5B MACF1 PLEC DDX21 SON AHNAK2	7.90e-10	724	107	16	36232890
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	COL5A1 ACACA ATRX MAP1B MAP2 MAP4 RALGAPB ASH1L LAMA3 RTN3 SUCLA2 SHROOM2 AHDC1 PCNX2 KIAA1671 ZC3H11A GTF3C1 SH3TC1 PAK3 MACF1 GOLGB1 FRMD3	7.96e-10	1489	107	22	28611215
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPHN TPR CACNA1E ILF3 APC2 TRIP11 MAGED2 SVIL YLPM1 EIF4G1 PAK3 GOLGA8B MACF1 CDH10 DYNC1H1 GOLGB1 EPB41L2 TP53BP1	8.96e-10	963	107	18	28671696
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CACNA1E ILF3 ATRX ABI3BP MAP1B RPN2 ASH1L USP8 GTF3C1 MAGED2 SBNO1 AHNAK CSPG4 YLPM1 EIF4G1 ANKRD30A EIF5B MACF1 PLEC DDX21 GOLGB1	2.65e-09	1442	107	21	35575683
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	ILF3 ACACA RPN2 LDHB CDC40 MAGED2 AHNAK TCF25 EIF5B PLEC DDX21 DYNC1H1 SON	2.90e-09	477	107	13	31300519
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	EP400 ATRX TOPBP1 RTN3 WASHC2A LDHB TRIP11 PAPOLG KIAA1671 ALMS1 MACF1 TOPORS GOLGB1 TP53BP1	3.85e-09	588	107	14	38580884
Pubmed	Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development.	TCF12 MAP1B MACF1 PLEC DYNC1H1 GOLGB1 SON	3.93e-09	76	107	7	27542412
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	TPR MAP4 AHNAK EIF4G1 EIF5B PLEC DYNC1H1 GOLGB1 EPB41L2 AHNAK2	7.36e-09	256	107	10	33397691
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TPR ILF3 ACACA ATRX MAP4 RPN2 RTN3 SUCLA2 LDHB URB1 ZC3H11A GTF3C1 CDC40 MAGED2 SBNO1 EIF4G1 EIF5B DDX21 DYNC1H1 EPB41L2	1.24e-08	1425	107	20	30948266
Pubmed	Caspr2 interacts with type 1 inositol 1,4,5-trisphosphate receptor in the developing cerebellum and regulates Purkinje cell morphology.	MAP1B MAP2 MAP4 ITPR1	1.75e-08	10	107	4	32675284
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	TPR ILF3 EP400 ATRX MAP4 ZC3H11A PIP YLPM1 DDX21 RSBN1L	1.91e-08	283	107	10	30585729
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TPR ATRX MAP4 ASH1L RHOT2 SHROOM2 WASHC2A ITPR1 ADH5 URB1 ZC3H11A VCAN MACF1 PLEC DDX21 GOLGB1 TP53BP1	3.63e-08	1084	107	17	11544199
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ILF3 EP400 MAP4 SUCLA2 CDC40 MAGED2 AHNAK PIP SVIL YLPM1 EIF4G1 LRRC8A GOLGA8B PLEC DDX21 RSBN1L DYNC1H1 EPB41L2 SON	3.70e-08	1371	107	19	36244648
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	TPR ILF3 MAP1B MAP4 RPN2 MAGED2 AHNAK EIF4G1 TCF25 EIF5B MACF1 DYNC1H1 GOLGB1 EPB41L2	3.93e-08	708	107	14	39231216
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	CACNA1E PERM1 ZFPM1 SHROOM2 PCNX2 LPIN1 ALMS1 PCDH11X ZNF653	4.72e-08	233	107	9	37704626
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	MAP1B MAP4 LDHB AHNAK SVIL EIF4G1 PLEC DDX21 DYNC1H1 AHNAK2	4.77e-08	312	107	10	37120454
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	TPR ILF3 FAT3 AHNAK PIP MACF1 PLEC DDX21 GOLGB1	4.90e-08	234	107	9	36243803
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	TPR ILF3 ACACA MAP4 RPN2 LDHB USP8 SBNO1 AHNAK EIF4G1 EIF5B MACF1 PLEC DDX21 DYNC1H1 GOLGB1 EPB41L2 SON AHNAK2	6.07e-08	1415	107	19	28515276
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	GPHN TPR TCF12 EP400 MAP1B TRIM24 ZC3H11A GTF3C1 SH3TC1 EIF4G1 EIF5B DDX21 DYNC1H1 TP53BP1 FOXC2	6.10e-08	857	107	15	25609649
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	ILF3 ACACA RPN2 RHOT2 PAPOLG URB1 ZC3H11A GTF3C1 AHNAK PIP YLPM1 PLEC DDX21 RSBN1L TP53BP1 SON	6.26e-08	989	107	16	36424410
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	TPR ILF3 ACACA MAP1B MAP4 LDHB ADH5 GTF3C1 MAGED2 AHNAK SVIL EIF4G1 EIF5B MACF1 PLEC DYNC1H1 EPB41L2	8.36e-08	1149	107	17	35446349
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	ILF3 MAP4 TRIM24 EIF4G1 EIF5B DDX21 GOLGB1 EPB41L2	8.89e-08	179	107	8	36261009
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	GPHN TPR ILF3 TOPBP1 WASHC2A ITPR1 URB1 GTF3C1 CDC40 AHNAK PIP SVIL YLPM1 EIF4G1 DDX21 DYNC1H1 TP53BP1	9.00e-08	1155	107	17	20360068
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ILF3 EP400 EZH2 GTF3C1 SBNO1 YLPM1 TCF25 EIF5B RSBN1L TP53BP1	1.09e-07	341	107	10	32971831
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	TCF12 ATRX MAP1B RPN2 RALGAPB GMIP EZH2 ITPR1 LPIN1 GTF3C1 CDC40 TCF25 RSBN1L	1.09e-07	650	107	13	38777146
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	TPR ILF3 ATRX TOPBP1 LDHB ITPR1 ZC3H11A AHNAK PIP SVIL PLEC DDX21 SON	1.13e-07	652	107	13	31180492
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	TPR ILF3 MAP1B LDHB USP8 EIF5B PLEC DYNC1H1 TP53BP1 SON	1.18e-07	344	107	10	30333137
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	TPR ILF3 KIAA1671 CDC40 AHNAK SVIL YLPM1 EIF4G1 EIF5B MACF1 PLEC DDX21 EPB41L2	1.30e-07	660	107	13	32780723
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	MAP4 LDHB AHNAK SVIL EIF4G1 MACF1 PLEC DYNC1H1	1.46e-07	191	107	8	33762435
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	ACACA MAP1B MAP4 RPN2 SUCLA2 LDHB ZC3H11A OXCT1 MAGED2 AHNAK YLPM1 EIF4G1 EIF5B DDX21 GOLGB1 TP53BP1 SON AHNAK2	1.89e-07	1367	107	18	32687490
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	ABCA2 ILF3 ACACA RPN2 ASH1L RTN3 ADH5 AHNAK EIF4G1 EIF5B MACF1 PLEC DYNC1H1 AHNAK2	1.94e-07	807	107	14	30575818
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	TPR ILF3 MAP1B MAP4 RPN2 LDHB ZC3H11A AHNAK YLPM1 EIF4G1 EIF5B PLEC DDX21 DYNC1H1	2.00e-07	809	107	14	32129710
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	ACACA MAP4 RPN2 AHNAK EIF4G1 ANKRD30A EIF5B PLEC	2.25e-07	202	107	8	33005030
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	TPR ILF3 MAP4 URB1 YLPM1 EIF4G1 EIF5B DDX21	2.25e-07	202	107	8	24639526
Pubmed	Functional proteomics mapping of a human signaling pathway.	ATRX ASH1L RHOT2 CSPG4 YLPM1 EIF4G1 MACF1 PLEC TOPORS DYNC1H1 GOLGB1 SON	2.97e-07	591	107	12	15231748
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	TPR ILF3 RPN2 PARP3 TOPBP1 LDHB MAGED2 EIF4G1 MACF1 PLEC DDX21 DYNC1H1 GOLGB1 EPB41L2	3.48e-07	847	107	14	35235311
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	MAP1B MAP4 WASHC2A ZC3H11A GTF3C1 AHNAK EIF4G1 EPB41L2	3.61e-07	215	107	8	35973513
Pubmed	Human transcription factor protein interaction networks.	TCF12 EP400 ATRX RPN2 RHOT2 TRIM24 WASHC2A KIAA1671 GTF3C1 ALMS1 MAGED2 SVIL YLPM1 EIF4G1 ELF1 DYNC1H1 RAI2 TP53BP1	3.61e-07	1429	107	18	35140242
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	COL5A1 ILF3 ABI3BP LAMA3 VCAN CSPG4 TNXB	3.65e-07	146	107	7	27068509
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	TPR ILF3 MAP4 LDHB ALMS1 AHNAK EIF4G1 EIF5B PLEC DDX21 TP53BP1	3.86e-07	494	107	11	26831064
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	EP400 ATRX MAP1B EZH2 GTF3C1 MAGED2 AHNAK DDX21 EPB41L2 TP53BP1	4.11e-07	394	107	10	27248496
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	TPR MAP1B MAP2 MAP4 ZC3H11A MAGED2 AHNAK VCAN SVIL EIF5B MACF1	4.18e-07	498	107	11	36634849
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	TPR ACACA MAP4 RPN2 LDHB GTF3C1 MAGED2 AHNAK DYNC1H1 EPB41L2	4.62e-07	399	107	10	37536630
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	GPHN TPR ILF3 MAP1B ZC3H11A AHNAK YLPM1 EPB41L2 TP53BP1 SON	4.62e-07	399	107	10	35987950
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	GPHN ACACA MAP2 MAP4 WASHC2A LDHB USP8 OXCT1 MAGED2 SBNO1 AHNAK EIF4G1 EIF5B MACF1 PLEC DYNC1H1 EPB41L2 AHNAK2	4.69e-07	1455	107	18	22863883
Pubmed	Defining the membrane proteome of NK cells.	ABCA2 ILF3 RPN2 RHOT2 LDHB ITPR1 PAPOLG INTS5 GTF3C1 MAGED2 AHNAK EIF4G1 LRRC8A DDX21 DYNC1H1 GOLGB1	5.82e-07	1168	107	16	19946888
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	GPHN CACNA1E ATRX MAP1B MAP2 RTN3 MACF1 EPB41L2	6.21e-07	231	107	8	16452087
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	MAP1B MAP4 TOPBP1 URB1 ZC3H11A GTF3C1 CDC40 MAGED2 EIF4G1 TCF25 MACF1 DDX21 SON	6.34e-07	759	107	13	35915203
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ILF3 ATRX MAP2 RPN2 RALGAPB RTN3 SUCLA2 TRIM24 WASHC2A ITPR1 LIFR URB1 EIF5B MACF1 DDX21 GOLGB1 EPB41L2 TP53BP1	6.42e-07	1487	107	18	33957083
Pubmed	Analysis of HIV-1 Gag protein interactions via biotin ligase tagging.	TPR MAP4 AHNAK EIF4G1 EPB41L2	7.04e-07	54	107	5	25631074
Pubmed	CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.	ILF3 MAP1B MAP4 RHOT2 MAGED2 AHNAK CSPG4 PIP EIF4G1 EIF5B	7.04e-07	418	107	10	35338135
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	EP400 ATRX MAP4 RALGAPB TOPBP1 EZH2 AHDC1 KIAA1671 URB1 INTS5 ZC3H11A EIF4G1 EIF5B MACF1 RSBN1L GOLGB1 EPB41L2 SON	7.07e-07	1497	107	18	31527615
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	ABI3BP AHNAK VCAN EIF4G1 PLEC DDX21 EPB41L2 TP53BP1	7.07e-07	235	107	8	30258100
Pubmed	BioID-based proteomic analysis of the Bid interactome identifies novel proteins involved in cell-cycle-dependent apoptotic priming.	MAP4 EIF4G1 DYNC1H1 SON AHNAK2	7.72e-07	55	107	5	33067418
Pubmed	The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.	TPR ILF3 ACACA LDHB KIAA1671 ZC3H11A AHNAK EIF4G1 DDX21	8.87e-07	330	107	9	32529326
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	KLHL24 EP400 APC2 KIAA1671 CDC40 ARHGAP31 YLPM1 PLEC DYNC1H1 SON	9.09e-07	430	107	10	35044719
Pubmed	Mitochondrial phosphoproteome revealed by an improved IMAC method and MS/MS/MS.	ACACA ITPR1 HACL1 PLEC BCL2L13	9.25e-07	57	107	5	17208939
Pubmed	Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN.	ILF3 MAP1B MAP4 LDHB SVIL EIF5B DDX21 DYNC1H1 EPB41L2	9.80e-07	334	107	9	30425250
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	TPR ITPR1 URB1 AHNAK PIP PLEC DDX21 DYNC1H1 SON	1.14e-06	340	107	9	29478914
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	TPR ILF3 MAP4 LDHB ITPR1 MAGED2 AHNAK SVIL TCF25 EIF5B PLEC DDX21 DYNC1H1 SON	1.34e-06	949	107	14	36574265
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	MAP4 TRIP11 KIAA1671 USP8 AHNAK SVIL EIF4G1 GOLGA8B MACF1 PLEC GOLGB1	1.43e-06	565	107	11	25468996
Pubmed	Perinatal lethality of microtubule-associated protein 1B-deficient mice expressing alternative isoforms of the protein at low levels.	MAP1B MAP2 MAP4	1.57e-06	8	107	3	11085878
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	TCF12 ACACA EP400 ATRX TOPBP1 TRIM24 LDHB SBNO1 DYNC1H1	1.70e-06	357	107	9	37059091
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	TCF12 MAP4 TRIM24 ZC3H11A ALMS1 ARHGAP31 SVIL	1.73e-06	184	107	7	32908313
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPHN ILF3 MAP1B MAP2 MAP4 RTN3 SUCLA2 SHROOM2 LDHB TRIP11 VCAN SVIL EIF4G1 MACF1 PLEC DYNC1H1 EPB41L2	1.76e-06	1431	107	17	37142655
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	TPR MAP1B AHNAK EIF4G1 GOLGB1 AHNAK2	1.83e-06	118	107	6	30979931
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	MAP4 LDHB AHNAK SVIL EIF4G1 EIF5B PLEC DDX21 DYNC1H1 GOLGB1 EPB41L2	1.85e-06	580	107	11	35676659
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	ILF3 ACACA MAP1B RHOT2 SUCLA2 TRIM24 OXCT1 GTF3C1 DYNC1H1 EPB41L2 TP53BP1 SON	1.85e-06	704	107	12	29955894
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TPR ILF3 ATRX MAGED2 AHNAK YLPM1 MACF1 PLEC DDX21 DYNC1H1 GOLGB1	1.91e-06	582	107	11	20467437
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	TPR ILF3 ACACA MAP4 LDHB AHNAK EIF4G1 EIF5B MACF1 PLEC DDX21 DYNC1H1	1.93e-06	707	107	12	19738201
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ILF3 EP400 ATRX RPN2 TOPBP1 EZH2 AHDC1 URB1 INTS5 ZC3H11A GTF3C1 CDC40 AHNAK YLPM1 DDX21 SON	2.21e-06	1294	107	16	30804502
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	ILF3 ACACA EP400 MAP4 RPN2 SUCLA2 LDHB CDC40 AHNAK EIF4G1 EIF5B PLEC DDX21 RSBN1L DYNC1H1 SON	2.79e-06	1318	107	16	30463901
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TPR ILF3 EP400 ATRX MAP4 ZC3H11A GTF3C1 SBNO1 AHNAK YLPM1 EIF4G1 EIF5B PLEC SON	2.88e-06	1014	107	14	32416067
Pubmed	Identification of three human type-II classic cadherins and frequent heterophilic interactions between different subclasses of type-II classic cadherins.	CDH8 CDH10 CDH12	3.34e-06	10	107	3	10861224
Pubmed	Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue.	CDH8 CDH10 CDH12	3.34e-06	10	107	3	2059658
Pubmed	HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.	ZC3H11A MACF1 DYNC1H1 GOLGB1	3.66e-06	34	107	4	25925205
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	TCF12 ACACA RPN2 LDHB ITPR1 AHNAK SVIL TCF25 EIF5B PLEC	3.68e-06	503	107	10	36217030
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	ACACA EP400 RPN2 TRIM24 TRIP11 FSCB ITPR1 USP8 EIF4G1 ASTN1 DYNC1H1 GOLGB1	3.74e-06	754	107	12	35906200
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	GPHN TPR EP400 WASHC2A YLPM1 DDX21 DYNC1H1 GOLGB1 TP53BP1 SON	3.88e-06	506	107	10	30890647
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	ILF3 MAP4 MAGED2 AHNAK TCF25 DDX21 DYNC1H1 AHNAK2	4.14e-06	298	107	8	30737378
Pubmed	Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.	GPHN MAP1B MAP2 RTN3 SUCLA2 LDHB ITPR1 PLEC DYNC1H1	4.54e-06	403	107	9	30562941
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	ILF3 ACACA RPN2 MAGED2 EIF4G1 EIF5B PLEC DDX21 DYNC1H1 EPB41L2 SON	4.58e-06	638	107	11	33239621
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	EP400 RALGAPB WASHC2A USP8 ZC3H11A TCF25 MACF1 DYNC1H1 SON	4.92e-06	407	107	9	12693553
Interaction	PML interactions	ILF3 TCF12 ACACA EP400 ATRX MAP1B MAP4 TOPBP1 EZH2 TRIM24 LDHB AHDC1 PAPOLG INTS5 ZC3H11A OXCT1 MAGED2 SBNO1 AHNAK PIP EIF4G1 TOPORS EPB41L2 TP53BP1 AHNAK2	1.40e-11	933	107	25	int:PML
Interaction	NAA40 interactions	GPHN TPR ILF3 ACACA EP400 ATRX MAP1B MAP4 LDHB TRIP11 KIAA1671 USP8 ZC3H11A ALMS1 AHNAK YLPM1 EIF5B MACF1 DDX21 RSBN1L GOLGB1 EPB41L2 TP53BP1 SON AHNAK2	3.85e-11	978	107	25	int:NAA40
Interaction	SIRT7 interactions	TPR COL5A1 ACACA MAP1B MAP4 RPN2 URB1 ZC3H11A GTF3C1 AHNAK YLPM1 EIF4G1 EIF5B MACF1 PLEC DDX21 DYNC1H1 EPB41L2 TP53BP1 SON	2.00e-09	744	107	20	int:SIRT7
Interaction	MECP2 interactions	ILF3 EP400 ATRX MAP1B MAP2 RPN2 EZH2 LDHB AHDC1 URB1 INTS5 GTF3C1 CDC40 VCAN YLPM1 EIF4G1 EIF5B MACF1 PLEC DDX21 TNXB DYNC1H1 EPB41L2 TP53BP1 SON	1.12e-08	1287	107	25	int:MECP2
Interaction	OBSL1 interactions	TPR ILF3 EP400 MAP2 EZH2 URB1 INTS5 ZC3H11A GTF3C1 AHNAK YLPM1 TCF25 EIF5B MACF1 PLEC DDX21 RSBN1L DYNC1H1 GOLGB1 SON	5.04e-08	902	107	20	int:OBSL1
Interaction	SUMO2 interactions	TPR EP400 ATRX MAP4 EZH2 TRIM24 ZC3H11A GTF3C1 AHNAK EIF4G1 PLEC TOPORS DDX21 DYNC1H1 TP53BP1 AHNAK2	8.97e-08	591	107	16	int:SUMO2
Interaction	CIT interactions	TPR ILF3 EP400 RPN2 ASH1L EZH2 KIAA1671 URB1 INTS5 ALMS1 CDC40 MAGED2 AHNAK SVIL EIF4G1 TCF25 EIF5B MACF1 ELF1 PLEC DDX21 RSBN1L DYNC1H1 SON AHNAK2	1.15e-07	1450	107	25	int:CIT
Interaction	ATOH1 interactions	TCF12 MAP1B MACF1 PLEC DYNC1H1 GOLGB1 SON	2.25e-07	80	107	7	int:ATOH1
Interaction	ITGB3 interactions	TPR ILF3 MAP1B USP8 EIF5B PLEC DYNC1H1 TP53BP1 SON	3.09e-07	170	107	9	int:ITGB3
Interaction	CCDC8 interactions	TPR ILF3 EP400 MAP1B MAP4 KIAA1671 GTF3C1 AHNAK SVIL EIF4G1 MACF1 PLEC DDX21 DYNC1H1 GOLGB1 EPB41L2	3.67e-07	656	107	16	int:CCDC8
Interaction	PINK1 interactions	ILF3 ACACA MAP1B RPN2 RHOT2 LDHB CDC40 MAGED2 AHNAK TCF25 EIF5B PLEC DDX21 DYNC1H1 SON AHNAK2	5.80e-07	679	107	16	int:PINK1
Interaction	KIF20A interactions	ILF3 APC2 RHOT2 EZH2 TRIP11 ITPR1 PCNX2 KIAA1671 LPIN1 URB1 ALMS1 AHNAK SVIL YLPM1 MACF1 HACL1 PLEC DDX21 SON AHNAK2	5.94e-07	1052	107	20	int:KIF20A
Interaction	MEX3A interactions	KLHL24 AHDC1 FAM78A ZC3H11A AHNAK SVIL EIF4G1 MACF1 PLEC DYNC1H1 SON AHNAK2	9.39e-07	384	107	12	int:MEX3A
Interaction	SMC5 interactions	TPR ILF3 ACACA EP400 ATRX MAP1B MAP4 TOPBP1 TRIM24 LDHB ZC3H11A AHNAK YLPM1 EIF4G1 EIF5B DDX21 RSBN1L TP53BP1 SON	1.20e-06	1000	107	19	int:SMC5
Interaction	CHMP4B interactions	COL5A1 ILF3 ACACA ATRX EZH2 ITPR1 KIAA1671 USP8 URB1 AHNAK SVIL PLEC DDX21 GOLGB1 SON AHNAK2	1.42e-06	727	107	16	int:CHMP4B
Interaction	MEN1 interactions	COL5A1 ILF3 EP400 ATRX EZH2 LDHB AHDC1 URB1 ZC3H11A GTF3C1 SBNO1 YLPM1 EIF4G1 TCF25 EIF5B DDX21 RSBN1L TP53BP1 SON	1.83e-06	1029	107	19	int:MEN1
Interaction	TOP3B interactions	ABCA2 ACACA EP400 TMCO6 RHOT2 ZFPM1 WASHC2A AHDC1 PCNX2 URB1 INTS5 ZC3H11A SH3TC1 AHNAK CSPG4 SVIL EIF4G1 C19orf44 PLEC BCL2L13 DYNC1H1 TP53BP1 AHNAK2	2.20e-06	1470	107	23	int:TOP3B
Interaction	PFN1 interactions	GPHN TPR RALGAPB RTN3 EZH2 TRIM24 TRIP11 KIAA1671 ALMS1 MACF1 GOLGB1 TP53BP1 AHNAK2	3.04e-06	509	107	13	int:PFN1
Interaction	MAPRE1 interactions	MAP1B MAP2 APC2 EZH2 ALMS1 SVIL EIF4G1 EIF5B MACF1 PLEC DDX21 ZNF653 DYNC1H1	3.38e-06	514	107	13	int:MAPRE1
Interaction	PSMD14 interactions	ILF3 RPN2 EZH2 SUCLA2 LIFR INTS5 MAGED2 EIF4G1 PCDH11X PLEC RSBN1L TP53BP1 AHNAK2	4.44e-06	527	107	13	int:PSMD14
Interaction	SNCA interactions	TPR ILF3 MAP1B MAP2 MAP4 USP8 ZC3H11A MAGED2 AHNAK VCAN SVIL EIF5B PAK3 MACF1 DYNC1H1	5.69e-06	716	107	15	int:SNCA
Interaction	TRIM37 interactions	ILF3 TCF12 MAP4 RPN2 EZH2 TRIM24 ZC3H11A ALMS1 ARHGAP31 AHNAK PIP SVIL PLEC DDX21	6.16e-06	630	107	14	int:TRIM37
Interaction	EFTUD2 interactions	TPR ILF3 ACACA MAP4 RPN2 EZH2 TRIM24 LDHB USP8 CDC40 SBNO1 AHNAK EIF4G1 EIF5B MACF1 PLEC DDX21 DYNC1H1 GOLGB1 EPB41L2 SON AHNAK2	6.21e-06	1449	107	22	int:EFTUD2
Interaction	SNRNP40 interactions	ILF3 TCF12 ACACA EP400 TRIM24 AHDC1 PAPOLG URB1 CDC40 ELF1 DDX21 RSBN1L EPB41L2 SON	6.98e-06	637	107	14	int:SNRNP40
Interaction	PTEN interactions	TPR ILF3 ACACA ATRX RPN2 RTN3 TMCO6 EZH2 TRIM24 LDHB USP8 MAGED2 TCF25 PLEC DDX21 TP53BP1 SON	7.71e-06	929	107	17	int:PTEN
Interaction	YWHAG interactions	GPHN MAP2 RALGAPB RTN3 EZH2 SHROOM2 LDHB TRIP11 KIAA1671 LPIN1 USP8 ALMS1 SVIL EIF4G1 TCF25 MACF1 DYNC1H1 EPB41L2 SON AHNAK2	8.03e-06	1248	107	20	int:YWHAG
Interaction	USP14 interactions	ILF3 MAP1B MAP4 LDHB AHNAK SVIL EIF5B MACF1 DDX21 DYNC1H1 EPB41L2 AHNAK2	1.12e-05	489	107	12	int:USP14
Interaction	PHLPP1 interactions	TPR MAP4 AHNAK EIF4G1 EIF5B PLEC DYNC1H1 GOLGB1 EPB41L2 AHNAK2	1.13e-05	333	107	10	int:PHLPP1
Interaction	RICTOR interactions	MAP1B MAP4 EZH2 WASHC2A LDHB ZC3H11A GTF3C1 AHNAK SVIL EIF4G1 PLEC DDX21 DYNC1H1 EPB41L2 AHNAK2	1.14e-05	759	107	15	int:RICTOR
Interaction	NEIL3 interactions	ACACA MAP1B MAP4 PIP PLEC RSBN1L	1.30e-05	97	107	6	int:NEIL3
Interaction	LRRC31 interactions	ACACA MAP4 RPN2 AHNAK EIF4G1 ANKRD30A EIF5B PLEC	1.38e-05	205	107	8	int:LRRC31
Interaction	MCM2 interactions	TPR ILF3 ACACA EP400 ATRX RPN2 EZH2 TRIM24 LDHB MAGED2 SBNO1 AHNAK PIP EIF4G1 MACF1 PLEC DDX21 DYNC1H1	1.46e-05	1081	107	18	int:MCM2
Interaction	FGD5 interactions	MAP4 LDHB AHNAK SVIL EIF4G1 MACF1 PLEC DYNC1H1	1.48e-05	207	107	8	int:FGD5
Interaction	RNPS1 interactions	ILF3 EZH2 TRIM24 ZC3H11A GTF3C1 CDC40 TOPORS DDX21 RSBN1L EPB41L2 SON	1.63e-05	425	107	11	int:RNPS1
Interaction	USP7 interactions	TPR ILF3 TCF12 ATRX FAT3 EZH2 ZNF414 ZC3H11A MAGED2 SASH3 AHNAK PIP SVIL YLPM1 TCF25 MACF1 PLEC DDX21 DYNC1H1 GOLGB1	1.69e-05	1313	107	20	int:USP7
Interaction	DYNLL1 interactions	GPHN TPR ILF3 MAP1B EZH2 EIF4G1 C19orf44 RSBN1L DYNC1H1 GOLGB1 EPB41L2 TP53BP1	1.70e-05	510	107	12	int:DYNLL1
Interaction	ECT2 interactions	COL5A1 ILF3 LAMTOR5 LDHB ITPR1 KIAA1671 AHNAK SVIL EIF5B MACF1 HACL1 PLEC DDX21 DYNC1H1 SON AHNAK2	1.76e-05	887	107	16	int:ECT2
Interaction	SFN interactions	MAP1B MAP2 MAP4 TRIP11 KIAA1671 USP8 ALMS1 SVIL EIF4G1 EIF5B MACF1 PLEC EPB41L2 AHNAK2	1.77e-05	692	107	14	int:SFN
Interaction	ACE2 interactions	TPR ILF3 ACACA ABI3BP MAP4 RPN2 SHROOM2 LDHB TRIP11 CDC40 PIP YLPM1 EIF4G1 PLEC DDX21 DYNC1H1 GOLGB1 AHNAK2	1.98e-05	1106	107	18	int:ACE2
Interaction	CNTNAP2 interactions	MAP1B MAP2 MAP4 ITPR1 PAK3 MACF1 EPB41L2	2.16e-05	158	107	7	int:CNTNAP2
Interaction	CBX1 interactions	ATRX ABI3BP MAP4 GMIP EZH2 TRIM24 AHDC1 GTF3C1 EPB41L2	2.31e-05	288	107	9	int:CBX1
Interaction	MOB3C interactions	TPR ACACA MAP4 RPN2 LDHB GTF3C1 MAGED2 AHNAK DYNC1H1 EPB41L2	2.43e-05	364	107	10	int:MOB3C
Interaction	BRCA1 interactions	TPR ILF3 ACACA MAP4 TOPBP1 EZH2 TRIM24 LDHB TRIP11 ITPR1 ZC3H11A ALMS1 AHNAK EIF4G1 EIF5B PLEC DDX21 DYNC1H1 TP53BP1	2.89e-05	1249	107	19	int:BRCA1
Interaction	TRIM33 interactions	ILF3 TCF12 MAP4 EZH2 TRIM24 EIF4G1 EIF5B DDX21 GOLGB1 EPB41L2 TP53BP1	2.92e-05	453	107	11	int:TRIM33
Interaction	DSCAM interactions	ATRX APC2 TRIP11 MACF1 ASTN1 PLEC DYNC1H1	3.58e-05	171	107	7	int:DSCAM
Interaction	SUZ12 interactions	ILF3 ACACA EP400 EZH2 LDHB AHDC1 GTF3C1 ALMS1 CDC40 MAGED2 PLEC DYNC1H1 SON	3.70e-05	644	107	13	int:SUZ12
Interaction	LAMP1 interactions	ILF3 RPN2 LAMTOR5 RALGAPB EZH2 TRIP11 CSPG4 LRRC8A MACF1 ASTN1 GOLGB1 EPB41L2 AHNAK2	3.70e-05	644	107	13	int:LAMP1
Interaction	CBX3 interactions	EP400 ATRX TOPBP1 EZH2 TRIM24 AHDC1 OXCT1 GTF3C1 SBNO1 EIF5B MACF1 RSBN1L TP53BP1	3.82e-05	646	107	13	int:CBX3
Interaction	HDLBP interactions	ILF3 EP400 RPN2 TOPBP1 EZH2 SUCLA2 CDC40 AHNAK PIP SVIL YLPM1 EIF4G1 GOLGA8B RSBN1L DYNC1H1	4.54e-05	855	107	15	int:HDLBP
Interaction	SPDL1 interactions	ABI3BP AHNAK VCAN YLPM1 EIF4G1 PLEC DDX21 EPB41L2 TP53BP1	4.66e-05	315	107	9	int:SPDL1
Interaction	DCPS interactions	TPR EZH2 ITPR1 URB1 AHNAK PIP PLEC DDX21 DYNC1H1 SON	4.74e-05	394	107	10	int:DCPS
Interaction	SNRPA interactions	ILF3 ACACA MAP1B EZH2 TRIM24 ZC3H11A CDC40 YLPM1 DDX21 DYNC1H1 SON	5.13e-05	482	107	11	int:SNRPA
Interaction	KCNA3 interactions	TPR ILF3 MAP1B MAP4 RPN2 PAPOLG MAGED2 AHNAK EIF4G1 TCF25 EIF5B MACF1 DYNC1H1 GOLGB1 EPB41L2	5.60e-05	871	107	15	int:KCNA3
Interaction	YAP1 interactions	GPHN TPR ACACA MAP2 MAP4 RPN2 APC2 LDHB ZC3H11A GTF3C1 AHNAK YLPM1 PLEC DDX21 RSBN1L DYNC1H1 EPB41L2	6.26e-05	1095	107	17	int:YAP1
Interaction	CDC42 interactions	ACACA MAP4 RPN2 RALGAPB RTN3 RHOT2 GMIP EZH2 TRIP11 ITPR1 SBNO1 ARHGAP31 AHNAK CSPG4 EIF5B LRRC8A PAK3 BCL2L13 GOLGB1	6.30e-05	1323	107	19	int:CDC42
Interaction	EED interactions	TPR ILF3 ACACA EP400 MAP1B RPN2 EZH2 URB1 ZC3H11A GTF3C1 SVIL YLPM1 EIF4G1 EIF5B MACF1 PLEC DDX21 DYNC1H1 TP53BP1 SON	6.56e-05	1445	107	20	int:EED
Interaction	NUPR1 interactions	TPR ILF3 KIAA1671 CDC40 AHNAK SVIL YLPM1 EIF4G1 EIF5B MACF1 PLEC DDX21 EPB41L2	6.73e-05	683	107	13	int:NUPR1
Interaction	LGR4 interactions	TPR ILF3 MAP4 URB1 YLPM1 EIF4G1 EIF5B DDX21	7.88e-05	262	107	8	int:LGR4
Interaction	YWHAQ interactions	TPR ILF3 ACACA MAP2 MAP4 EZH2 LDHB TRIP11 KIAA1671 USP8 SVIL EIF4G1 MACF1 PLEC DYNC1H1 GOLGB1 EPB41L2	8.08e-05	1118	107	17	int:YWHAQ
Interaction	H2BC21 interactions	CACNA1E ILF3 EP400 ATRX MAP1B PARP3 EZH2 TRIM24 USP8 SASH3 AHNAK SVIL DYNC1H1	8.14e-05	696	107	13	int:H2BC21
Interaction	TOP1 interactions	TPR ILF3 EP400 RPN2 EZH2 TRIM24 ZC3H11A GTF3C1 CDC40 YLPM1 TOPORS DDX21 SON	8.14e-05	696	107	13	int:TOP1
Interaction	C2CD4B interactions	FAT3 SVIL TCF25 MACF1	8.66e-05	44	107	4	int:C2CD4B
Interaction	YWHAB interactions	MAP2 RALGAPB RTN3 EZH2 LDHB TRIP11 KIAA1671 USP8 SVIL EIF4G1 TCF25 MACF1 DYNC1H1 EPB41L2 SON AHNAK2	8.72e-05	1014	107	16	int:YWHAB
Interaction	XRCC6 interactions	TPR ILF3 EP400 ATRX MAP1B MAP4 EZH2 TRIM24 LDHB ZC3H11A PIP YLPM1 DDX21 RSBN1L TP53BP1	1.14e-04	928	107	15	int:XRCC6
Interaction	RBM39 interactions	ILF3 ACACA ATRX MAP1B RPN2 EZH2 LDHB ZC3H11A CDC40 MAGED2 PIP YLPM1 EIF4G1 DDX21 DYNC1H1 SON	1.20e-04	1042	107	16	int:RBM39
Interaction	AGR2 interactions	ABCA2 ILF3 ACACA RPN2 ASH1L RTN3 LDHB ADH5 AHNAK EIF4G1 EIF5B MACF1 PLEC DYNC1H1 AHNAK2	1.22e-04	934	107	15	int:AGR2
Interaction	DSCR9 interactions	ASH1L USP8 SBNO1 MACF1 RSBN1L DYNC1H1	1.34e-04	147	107	6	int:DSCR9
Interaction	NEUROG3 interactions	TCF12 GTF3C1 MAGED2 AHNAK MACF1 PLEC	1.44e-04	149	107	6	int:NEUROG3
Interaction	BID interactions	MAP4 EIF4G1 BCL2L13 DYNC1H1 SON AHNAK2	1.44e-04	149	107	6	int:BID
Interaction	CUL7 interactions	TPR ILF3 MAP1B RPN2 ZC3H11A AHNAK EIF4G1 EIF5B MACF1 PLEC DDX21 DYNC1H1 GOLGB1 SON	1.52e-04	845	107	14	int:CUL7
Interaction	SLFN11 interactions	TPR ACACA MAP1B LDHB GTF3C1 EIF4G1 EIF5B TP53BP1 SON	1.79e-04	376	107	9	int:SLFN11
Interaction	GSK3A interactions	ACACA MAP2 WASHC2A AHDC1 KIAA1671 ALMS1 MAGED2 SBNO1 MACF1 TOPORS	1.82e-04	464	107	10	int:GSK3A
Interaction	BAP1 interactions	TPR ILF3 ACACA MAP1B MAP4 LDHB ADH5 GTF3C1 MAGED2 AHNAK SVIL EIF4G1 EIF5B MACF1 ELF1 PLEC DYNC1H1 EPB41L2	1.82e-04	1314	107	18	int:BAP1
Interaction	BMI1 interactions	COL5A1 ILF3 ACACA ATRX EZH2 ZC3H11A GTF3C1 YLPM1 EIF4G1 PLEC DYNC1H1 SON	1.97e-04	659	107	12	int:BMI1
Interaction	PPP2R1A interactions	ACACA EP400 MAP1B MAP4 RPN2 EZH2 ZNF414 INTS5 CDC40 EIF4G1 DYNC1H1 FOXC2	2.14e-04	665	107	12	int:PPP2R1A
Interaction	FBXW7 interactions	EP400 MAP4 RPN2 RALGAPB EZH2 SUCLA2 GTF3C1 MAGED2 AHNAK EIF4G1 TCF25 EIF5B MACF1 PLEC DDX21 RSBN1L DYNC1H1	2.20e-04	1215	107	17	int:FBXW7
Interaction	ZC3H18 interactions	ILF3 ACACA MAP4 RPN2 EZH2 TRIM24 LDHB ZC3H11A CDC40 PIP TOPORS DDX21 EPB41L2 SON	2.23e-04	877	107	14	int:ZC3H18
Interaction	SAP18 interactions	TPR RPN2 EZH2 GTF3C1 CDC40 TOPORS DDX21 SON	2.24e-04	305	107	8	int:SAP18
Interaction	DDX39B interactions	ILF3 RPN2 TRIM24 ZC3H11A CDC40 PIP SVIL PLEC DDX21 DYNC1H1 TP53BP1	2.24e-04	570	107	11	int:DDX39B
Interaction	YWHAH interactions	ABCA2 ILF3 MAP2 RALGAPB TRIP11 KIAA1671 USP8 ALMS1 AHNAK SVIL EIF4G1 MACF1 NR3C2 PLEC EPB41L2 AHNAK2	2.27e-04	1102	107	16	int:YWHAH
Interaction	PSMD13 interactions	ACACA MAP1B MAP2 MAP4 EZH2 EIF4G1 DYNC1H1 TP53BP1	2.29e-04	306	107	8	int:PSMD13
Interaction	SLX4 interactions	TCF12 ACACA EP400 ATRX TOPBP1 TRIM24 LDHB SBNO1 PIP DYNC1H1 TP53BP1	2.31e-04	572	107	11	int:SLX4
Interaction	ARF5 interactions	GPHN ACACA RPN2 EZH2 LDHB TRIP11 GOLGB1	2.34e-04	231	107	7	int:ARF5
Interaction	WEE2-AS1 interactions	TPR RPN2 GTF3C1 MAGED2 AHNAK PLEC	2.35e-04	163	107	6	int:WEE2-AS1
Interaction	PSMC5 interactions	ACACA MAP1B MAP2 MAP4 EZH2 TRIP11 EIF4G1 NR3C2 DYNC1H1 TP53BP1	2.55e-04	484	107	10	int:PSMC5
Interaction	RAE1 interactions	TPR ILF3 MAP1B MAP2 MAP4 OXCT1 DYNC1H1	2.67e-04	236	107	7	int:RAE1
Interaction	STIP1 interactions	TPR ILF3 ACACA RPN2 EZH2 ADH5 MAGED2 AHNAK EIF4G1 EIF5B PLEC DDX21 DYNC1H1 EPB41L2 SON	2.73e-04	1006	107	15	int:STIP1
Interaction	DUSP16 interactions	MAP1B WASHC2A TRIP11 KIAA1671 ALMS1 C19orf44 DYNC1H1	2.74e-04	237	107	7	int:DUSP16
Interaction	LEKR1 interactions	EZH2 TRIP11	2.76e-04	5	107	2	int:LEKR1
Interaction	DEFB131A interactions	LRRC8A AHNAK2	2.76e-04	5	107	2	int:DEFB131A
Interaction	DLST interactions	RPN2 EZH2 SUCLA2 LDHB MAGED2 YLPM1 EIF4G1 PLEC DDX21 DYNC1H1	2.82e-04	490	107	10	int:DLST
Interaction	ITGB1 interactions	TPR ACACA RPN2 LAMTOR5 EZH2 USP8 VCAN PLEC DYNC1H1	2.82e-04	400	107	9	int:ITGB1
Interaction	SPOP interactions	ILF3 RTN3 TRIM24 LDHB EIF5B PLEC TOPORS DDX21 DYNC1H1 TP53BP1	2.86e-04	491	107	10	int:SPOP
Interaction	CEBPA interactions	ILF3 TCF12 EP400 MAP4 RPN2 TRIM24 LDHB ZNF414 AHDC1 URB1 ZC3H11A GTF3C1 EIF5B MACF1 ELF1 DYNC1H1 TP53BP1	2.92e-04	1245	107	17	int:CEBPA
Interaction	LGALS9 interactions	ABCA2 ILF3 ACACA RPN2 LDHB URB1 CSPG4 LRRC8A DYNC1H1 GOLGB1 EPB41L2	2.93e-04	588	107	11	int:LGALS9
Interaction	HOOK1 interactions	ACACA WASHC2A TRIP11 KIAA1671 SVIL PLEC DYNC1H1	2.95e-04	240	107	7	int:HOOK1
Interaction	ISG15 interactions	ILF3 MAP4 RPN2 EZH2 LDHB AHNAK EIF4G1 PLEC DYNC1H1 AHNAK2	3.00e-04	494	107	10	int:ISG15
Interaction	PCNT interactions	ACACA TRIP11 KIAA1671 ALMS1 MACF1 PLEC TP53BP1	3.03e-04	241	107	7	int:PCNT
Interaction	NXPH1 interactions	RHOT2 SUCLA2 CSPG4	3.07e-04	25	107	3	int:NXPH1
Interaction	H2BC12 interactions	ATRX MAP1B MAP4 EZH2 AHNAK YLPM1 EIF5B PAK3	3.22e-04	322	107	8	int:H2BC12
GeneFamily	CD molecules\|Type II classical cadherins	CDH8 CDH10 CDH12	1.98e-05	13	76	3	1186
GeneFamily	Fibronectin type III domain containing	MYOM1 ABI3BP LIFR TIE1 ASTN1 TNXB	5.73e-05	160	76	6	555
GeneFamily	EF-hand domain containing\|Plakins	MACF1 PLEC	4.80e-04	8	76	2	939
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	KLHL24 ABCA2 TCF12 MAP1B PARP3 TMCO6 SHROOM2 TRIP11 ALMS1 SVIL YLPM1 PAK3 ASTN1 ELF1 HACL1 PLEC CDH10 EPB41L2	4.94e-07	1102	107	18	M2369
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	KLHL24 ABCA2 TCF12 MAP1B PARP3 TMCO6 SHROOM2 TRIP11 ALMS1 SVIL YLPM1 PAK3 ASTN1 ELF1 HACL1 PLEC CDH10 EPB41L2	6.57e-07	1124	107	18	MM1070
Coexpression	BILD_CTNNB1_ONCOGENIC_SIGNATURE	ATRX ASH1L URB1 VCAN ELF1 DYNC1H1	8.77e-07	79	107	6	M7102
Coexpression	GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP	TCF12 RALGAPB ZNF414 ITPR1 LPIN1 GTF3C1 SASH3 SVIL	1.71e-06	200	107	8	M8653
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	TPR EP400 ATRX RALGAPB ASH1L GMIP LDHB ITPR1 PAPOLG PCNX2 FAM78A LPIN1 ZC3H11A SBNO1 SASH3 AHNAK MACF1 ELF1 DYNC1H1 SON	2.31e-06	1492	107	20	M40023
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	CACNA1E ATRX MAP1B MAP2 APC2 LAMA3 RHOT2 SHROOM2 AHDC1 LPIN1 VCAN PCDH11X PAK3 GOLGA8B CDH8 FRMD3 AHNAK2	2.43e-06	1106	107	17	M39071
Coexpression	MARTINEZ_RB1_TARGETS_UP	TPR ABCA2 ILF3 TCF12 MAP1B MAP2 RPN2 WASHC2A LPIN1 ZC3H11A EIF4G1 PLEC BCL2L13	4.87e-06	690	107	13	M12224
Coexpression	SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	LAMA3 AHNAK PLEC DDX21	7.59e-06	31	107	4	M3732
Coexpression	MARTINEZ_RB1_TARGETS_UP	TPR ABCA2 ILF3 TCF12 MAP1B MAP2 RPN2 WASHC2A LPIN1 ZC3H11A EIF4G1 PLEC BCL2L13	1.05e-05	741	107	13	MM1037
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	ILF3 LAMTOR5 TOPBP1 EZH2 SUCLA2 ADH5 OXCT1 CDC40 SBNO1 TP53BP1	1.17e-05	434	107	10	M15150
Coexpression	BLALOCK_ALZHEIMERS_DISEASE_DN	ILF3 ATRX RPN2 LAMTOR5 RTN3 SUCLA2 ITPR1 ADH5 OXCT1 CDC40 PCDH11X PAK3 ASTN1 CDH8 CDH10 DYNC1H1 SON	1.20e-05	1248	107	17	M17728
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	ILF3 LAMTOR5 TOPBP1 EZH2 SUCLA2 ADH5 OXCT1 CDC40 SBNO1 TP53BP1	1.54e-05	448	107	10	MM1044
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP	RALGAPB LPIN1 CPQ GOLGA8B MACF1 NR3C2 TNXB	1.63e-05	196	107	7	M5381
Coexpression	GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP	GPHN RPN2 EZH2 AHNAK SVIL EIF4G1 LRRC8A	1.80e-05	199	107	7	M9491
Coexpression	GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP	TCF12 LAMTOR5 PCNX2 TCF25 EIF5B GOLGA8B DDX21	1.80e-05	199	107	7	M5404
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	ABCA2 EP400 MAP4 ITPR1 AHNAK VCAN TCF25 PLEC	1.81e-05	276	107	8	M3063
Coexpression	BROWNE_HCMV_INFECTION_16HR_DN	CACNA1E ADH5 SVIL MACF1 PLEC	2.33e-05	83	107	5	M19130
Coexpression	RODWELL_AGING_KIDNEY_NO_BLOOD_DN	KLHL24 LDHB ITPR1 ADH5 OXCT1 FRMD3	3.31e-05	148	107	6	M11837
Coexpression	MARTINEZ_TP53_TARGETS_DN	TPR ABCA2 ILF3 MAP4 RPN2 PARP3 LDHB LPIN1 PIP PLEC SON	4.39e-05	615	107	11	M8673
Coexpression	HOEBEKE_LYMPHOID_STEM_CELL_UP	TPR LPIN1 SH3TC1 MACF1 DDX21	4.93e-05	97	107	5	M14698
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	TPR ATRX MAP1B ZFPM1 INTS5 EIF4G1 EIF5B DDX21 EPB41L2 SON	5.36e-05	519	107	10	M3395
Coexpression	TABULA_MURIS_SENIS_LIVER_ENDOTHELIAL_CELL_OF_HEPATIC_SINUSOID_AGEING	TPR ATRX MAP4 LDHB SH3TC1 TCF25 MACF1 ELF1 EPB41L2	5.53e-05	418	107	9	MM3752
Coexpression	GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP	ILF3 MAP4 GMIP EIF4G1 EIF5B SON	7.17e-05	170	107	6	M5657
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	TPR ATRX MAP1B ZFPM1 INTS5 EIF4G1 EIF5B DDX21 EPB41L2 SON	7.80e-05	543	107	10	MM997
Coexpression	MARTINEZ_TP53_TARGETS_DN	TPR ABCA2 ILF3 MAP4 RPN2 PARP3 LDHB LPIN1 PIP PLEC SON	8.14e-05	659	107	11	MM1040
Coexpression	CHICAS_RB1_TARGETS_CONFLUENT	COL5A1 ABI3BP MAP1B IRAG1 SHROOM2 AHNAK NR3C2 RSBN1L EPB41L2 FOXC2	1.11e-04	567	107	10	M2129
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	CACNA1E MAP1B MAP2 SHROOM2 AHDC1 LPIN1 URB1 PAK3 GOLGA8B CDH8 FRMD3	1.44e-04	703	107	11	M39070
Coexpression	LIM_MAMMARY_STEM_CELL_UP	COL5A1 ABI3BP LAMA3 IRAG1 LIFR TIE1 SH3TC1 VCAN CSPG4	1.55e-04	479	107	9	M2573
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP	RALGAPB CPQ MACF1 NR3C2 TNXB SON	1.61e-04	197	107	6	M5378
Coexpression	BROWNE_HCMV_INFECTION_48HR_DN	EP400 ATRX MAP1B MAP2 TMCO6 LPIN1 ALMS1 CDC40 PIP	1.63e-04	482	107	9	M12144
Coexpression	LIM_MAMMARY_STEM_CELL_UP	COL5A1 ABI3BP LAMA3 IRAG1 LIFR TIE1 SH3TC1 VCAN CSPG4	1.65e-04	483	107	9	MM1082
Coexpression	GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN	LDHB PCNX2 SBNO1 CSPG4 ASTN1 CDH8	1.65e-04	198	107	6	M5545
Coexpression	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP	ABCA2 TCF12 TRIP11 AHDC1 LRRC8A PLEC	1.65e-04	198	107	6	M6025
Coexpression	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	PCNX2 ZC3H11A ALMS1 MACF1 ELF1 SON	1.70e-04	199	107	6	M7596
Coexpression	GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN	TPR ADH5 ALMS1 SASH3 AHNAK PLEC	1.70e-04	199	107	6	M7651
Coexpression	GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	ATRX GMIP PCNX2 MACF1 ELF1 SON	1.70e-04	199	107	6	M7607
Coexpression	GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP	MYOM1 APC2 TMCO6 PCNX2 TIE1 SON	1.70e-04	199	107	6	M6631
Coexpression	GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP	RTN3 LPIN1 GTF3C1 MAGED2 SVIL EIF4G1	1.70e-04	199	107	6	M4427
Coexpression	GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN	MAP2 ZFPM1 ITPR1 FAM78A OXCT1 LRRC8A	1.70e-04	199	107	6	M9170
Coexpression	GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP	ASH1L TOPBP1 ITPR1 PAPOLG ZC3H11A TP53BP1	1.70e-04	199	107	6	M5607
Coexpression	GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN	RPN2 EZH2 SUCLA2 MACF1 PLEC TP53BP1	1.75e-04	200	107	6	M8302
Coexpression	GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN	PARP3 TOPBP1 GMIP EZH2 INTS5 EPB41L2	1.75e-04	200	107	6	M6601
Coexpression	GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP	TCF12 OXCT1 MAGED2 ARHGAP31 LRRC8A PLEC	1.75e-04	200	107	6	M7175
Coexpression	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN	MAP2 RTN3 EZH2 GTF3C1 ALMS1 TP53BP1	1.75e-04	200	107	6	M9215
Coexpression	GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN	MAP4 SUCLA2 ITPR1 SBNO1 EIF5B EPB41L2	1.75e-04	200	107	6	M7505
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	TPR ATRX RALGAPB TOPBP1 CDC40 AHNAK VCAN EIF4G1 EIF5B PLEC AHNAK2	1.79e-04	721	107	11	M10237
Coexpression	CUI_TCF21_TARGETS_2_DN	ASH1L SHROOM2 TRIP11 LIFR AFAP1L2 ARHGAP31 AHNAK TCF25 MACF1 ELF1 SON FOXC2	1.93e-04	854	107	12	M1533
Coexpression	SENESE_HDAC3_TARGETS_UP	GPHN TPR KLHL24 MAP2 FAT3 ASH1L LPIN1 ZC3H11A EIF4G1	1.98e-04	495	107	9	M8451
Coexpression	AIZARANI_LIVER_C20_LSECS_3	MAP1B LIFR TIE1 EIF5B MACF1 DDX21 GOLGB1	2.13e-04	295	107	7	M39121
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	GPHN TCF12 ITPR1 SVIL NR3C2 FRMD3	2.16e-04	208	107	6	M39233
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_UP	ILF3 TCF12 MAP1B MAP2 PARP3 WASHC2A LPIN1 ZC3H11A EIF4G1 BCL2L13	2.38e-04	623	107	10	M15896
Coexpression	AIZARANI_LIVER_C9_LSECS_1	MAP1B LIFR TIE1 MACF1 DDX21 GOLGB1 EPB41L2	2.55e-04	304	107	7	M39113
Coexpression	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	TPR KLHL24 ILF3 ATRX LIFR ZC3H11A EIF4G1 SON	2.57e-04	404	107	8	M19488
Coexpression	CUI_TCF21_TARGETS_2_DN	ASH1L SHROOM2 TRIP11 LIFR AFAP1L2 ARHGAP31 AHNAK TCF25 MACF1 ELF1 SON FOXC2	2.75e-04	888	107	12	MM1018
Coexpression	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP	TPR ILF3 MAP1B LAMA3 TRIM24 OXCT1 MAGED2 VCAN DYNC1H1 EPB41L2 TP53BP1 FRMD3	2.84e-04	891	107	12	M45033
Coexpression	AIZARANI_LIVER_C29_MVECS_2	ABI3BP LIFR TIE1 ARHGAP31 AHNAK PLEC DDX21	3.05e-04	313	107	7	M39128
Coexpression	OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP	MAP4 PCNX2 SASH3 PLEC DYNC1H1	3.37e-04	146	107	5	M41190
Coexpression	RODWELL_AGING_KIDNEY_DN	KLHL24 LDHB ADH5 OXCT1 FRMD3	3.59e-04	148	107	5	M5408
Coexpression	PATIL_LIVER_CANCER	TPR ILF3 ACACA MAP1B RTN3 EZH2 TRIM24 CPQ DYNC1H1 TP53BP1	3.76e-04	660	107	10	M1195
Coexpression	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	COL5A1 VCAN FOXC2	3.94e-04	35	107	3	M11788
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	RALGAPB TRIM24 AHDC1 SON	3.94e-04	84	107	4	M13008
Coexpression	CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	COL5A1 VCAN FOXC2	4.28e-04	36	107	3	MM1212
Coexpression	DESCARTES_FETAL_LIVER_STELLATE_CELLS	FAT3 LIFR AFAP1L2 CSPG4 RAI2	5.13e-04	160	107	5	M40233
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_UP	ILF3 TCF12 MAP1B MAP2 PARP3 WASHC2A LPIN1 ZC3H11A EIF4G1 BCL2L13	5.25e-04	689	107	10	MM1041
CoexpressionAtlas	kidney_e13.5_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_100	FAT3 VCAN RAI2 FOXC2	5.65e-07	14	106	4	gudmap_kidney_e13.5_Podocyte_MafB_k1_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	KLHL24 ATRX MAP1B MAP2 FAT3 ASH1L LIFR SBNO1 VCAN PCDH11X PAK3	8.08e-07	330	106	11	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500	ATRX MAP4 ASH1L TRIM24 ZC3H11A EIF4G1 PCDH11X EPB41L2	1.54e-06	162	106	8	gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500	ATRX MAP4 FAT3 ASH1L ZC3H11A EIF4G1 EPB41L2	5.44e-06	136	106	7	gudmap_developingGonad_P2_epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	COL5A1 ATRX MAP4 FAT3 ASH1L TRIM24 ZC3H11A ARHGAP31 EIF4G1 PCDH11X TCF25 PLEC TOPORS EPB41L2 AHNAK2	8.81e-06	790	106	15	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	COL5A1 ATRX ABI3BP MAP4 FAT3 ASH1L ZC3H11A ARHGAP31 EIF4G1 TCF25 PLEC TOPORS TNXB EPB41L2 AHNAK2	1.01e-05	799	106	15	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	ATRX MAP4 ASH1L TRIM24 ZC3H11A EIF4G1 EPB41L2	1.04e-05	150	106	7	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	ATRX MAP4 ASH1L TRIM24 ZC3H11A EIF4G1 PLEC EPB41L2	1.05e-05	210	106	8	gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200	ATRX ASH1L ZC3H11A EIF4G1 EPB41L2	1.34e-05	61	106	5	gudmap_developingGonad_e12.5_epididymis_k2_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	ATRX RTN3 SUCLA2 TRIM24 ZC3H11A OXCT1 GTF3C1 YLPM1 MACF1 ASTN1 CDH8 GOLGB1 SON	1.52e-05	629	106	13	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	TPR KLHL24 ILF3 ATRX MAP1B FAT3 LIFR VCAN PCDH11X PAK3	1.61e-05	369	106	10	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500	ATRX ASH1L TRIM24 ZC3H11A EIF4G1 PCDH11X EPB41L2	1.64e-05	161	106	7	gudmap_developingGonad_e12.5_ovary_k3_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	ATRX MAP4 ASH1L TRIM24 ZC3H11A EIF4G1 PLEC EPB41L2	2.03e-05	230	106	8	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	TPR KLHL24 ILF3 MAP1B FAT3 LIFR SBNO1 VCAN EIF4G1 SON	2.32e-05	385	106	10	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	TPR ABI3BP APC2 EZH2 ADH5 AFAP1L2 OXCT1 ALMS1 CSPG4 YLPM1 PCDH11X MACF1 ASTN1 HACL1 CDH8 FRMD3	2.72e-05	978	106	16	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200	MAP1B MAP4 FAT3 VCAN PCDH11X ASTN1 CDH10	3.13e-05	178	106	7	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200	ATRX ASH1L ZC3H11A EIF4G1 EPB41L2	3.93e-05	76	106	5	gudmap_developingGonad_e16.5_epididymis_200_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	ATRX MAP1B RTN3 TRIM24 GTF3C1 YLPM1 PAK3 MACF1 CDH8 DYNC1H1 GOLGB1 SON	4.20e-05	595	106	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_500	ABI3BP PARP3 AHNAK AHNAK2	4.22e-05	39	106	4	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k1
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	COL5A1 MYOM1 ATRX ABI3BP MAP4 FAT3 ASH1L ZC3H11A EIF4G1 TCF25 PLEC TNXB EPB41L2 AHNAK2	4.23e-05	797	106	14	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	ATRX MAP4 FAT3 ASH1L TRIM24 LIFR ZC3H11A ARHGAP31 EIF4G1 PCDH11X TCF25 PLEC TOPORS EPB41L2	4.47e-05	801	106	14	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	TPR KLHL24 ILF3 ATRX MAP1B MAP4 FAT3 LAMA3 LIFR VCAN PCDH11X PAK3 ASTN1 CDH10	4.78e-05	806	106	14	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	KLHL24 ATRX MAP1B MAP2 MAP4 FAT3 ASH1L LIFR SBNO1 VCAN PCDH11X PAK3 ASTN1 CDH10	5.60e-05	818	106	14	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	TPR KLHL24 ILF3 MAP1B MAP4 FAT3 LIFR SBNO1 VCAN EIF4G1 PCDH11X ASTN1 CDH10 SON	5.60e-05	818	106	14	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX MAP4 ASH1L TRIM24 EIF4G1 PCDH11X PLEC EPB41L2	7.21e-05	275	106	8	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX MAP4 ASH1L TRIM24 ZC3H11A EIF4G1 PCDH11X EPB41L2	7.58e-05	277	106	8	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX MAP4 ASH1L ZC3H11A ARHGAP31 EIF4G1 PLEC EPB41L2	8.38e-05	281	106	8	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_200	ASH1L ZC3H11A EIF4G1 PCDH11X EPB41L2	9.32e-05	91	106	5	gudmap_developingGonad_e14.5_ epididymis_200_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	TPR ILF3 MAP1B FAT3 VCAN PCDH11X	1.03e-04	149	106	6	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000	ILF3 ACACA ATRX MAP1B MAP2 APC2 RTN3 GMIP GTF3C1 PAK3 MACF1 BCL2L13 CDH8 GOLGB1 TP53BP1	1.04e-04	979	106	15	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000	ATRX ASH1L ZC3H11A EIF4G1 PLEC EPB41L2	1.11e-04	151	106	6	gudmap_developingGonad_P2_ovary_1000_k5
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500	MAP4 FAT3 ASH1L ZC3H11A EIF4G1 EPB41L2	1.15e-04	152	106	6	gudmap_developingGonad_e18.5_epididymis_500_k4
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	TPR ATRX TOPBP1 EZH2 SUCLA2 TRIM24 ZC3H11A GTF3C1 YLPM1 MACF1 GOLGB1	1.20e-04	564	106	11	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500	ATRX ASH1L ZC3H11A EIF4G1 EPB41L2	1.26e-04	97	106	5	gudmap_developingGonad_e18.5_ovary_500_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX MAP4 ASH1L TRIM24 ZC3H11A EIF4G1 EPB41L2	1.37e-04	225	106	7	gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_500	MYOM1 ABI3BP MAP1B PARP3 IRAG1 AHNAK CSPG4 TNXB AHNAK2	1.43e-04	388	106	9	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500	ATRX ASH1L TRIM24 EIF4G1 EPB41L2	1.53e-04	101	106	5	gudmap_developingGonad_e14.5_ ovary_500_k1
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500	MYOM1 ATRX MAP4 FAT3 ASH1L ZC3H11A EIF4G1 TNXB EPB41L2	1.63e-04	395	106	9	gudmap_developingGonad_P2_epididymis_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	MAP1B FAT3 OXCT1 EIF5B PAK3 ASTN1 CDH8	1.65e-04	232	106	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#2	APC2 OXCT1 PCDH11X ASTN1 CDH8	1.67e-04	103	106	5	Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K2
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200	ATRX FAT3 ASH1L ZC3H11A EIF4G1 EPB41L2	1.87e-04	166	106	6	gudmap_developingGonad_e16.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200	ATRX FAT3 ASH1L ZC3H11A EIF4G1 EPB41L2	1.87e-04	166	106	6	gudmap_developingGonad_e18.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	ATRX MAP4 ASH1L TRIM24 ZC3H11A SBNO1 EIF4G1 EIF5B PAK3 PLEC TOPORS CDH10 EPB41L2	1.89e-04	806	106	13	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200	ATRX ASH1L ZC3H11A EIF4G1 PCDH11X EPB41L2	1.93e-04	167	106	6	gudmap_developingGonad_e14.5_ epididymis_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	ABCA2 ATRX MAP1B MAP2 FAT3 RTN3 EZH2 ALMS1 PAK3 CDH8	1.96e-04	498	106	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	kidney_e13.5_Podocyte_MafB_k-means-cluster#4_top-relative-expression-ranked_200	FAT3 VCAN RAI2	1.99e-04	23	106	3	gudmap_kidney_e13.5_Podocyte_MafB_k4_200
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	ATRX MAP4 FAT3 ASH1L TRIM24 ZC3H11A EIF4G1 PCDH11X EPB41L2	2.00e-04	406	106	9	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500	ATRX ASH1L ZC3H11A EIF4G1 EPB41L2	2.18e-04	109	106	5	gudmap_developingGonad_e16.5_ovary_500_k5
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500	ATRX ASH1L TRIM24 ZC3H11A EIF4G1 PCDH11X	2.26e-04	172	106	6	gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	GPHN MAP1B FAT3 PAPOLG ALMS1 PAK3 ASTN1 CDH8	2.42e-04	328	106	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#4	ABCA2 FAT3 APC2 OXCT1 PCDH11X ASTN1 CDH8	2.43e-04	247	106	7	Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_200	MAP1B FAT3 VCAN PCDH11X	2.46e-04	61	106	4	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_200
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	TPR ABCA2 TCF12 ATRX MAP1B FAT3 EZH2 TRIM24 PAPOLG URB1 ALMS1 PAK3 MACF1 ASTN1 TP53BP1	2.47e-04	1060	106	15	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	GPHN ATRX MAP1B FAT3 ASH1L RTN3 EZH2 PAPOLG OXCT1 ALMS1 PAK3 ASTN1 CDH8	2.55e-04	831	106	13	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX MAP4 ASH1L ZC3H11A EIF4G1 PLEC EPB41L2	2.55e-04	249	106	7	gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2	ABCA2 FAT3 APC2 OXCT1 PCDH11X ASTN1 CDH8	2.55e-04	249	106	7	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500	KLHL24 MAP1B MAP2 MAP4 FAT3 VCAN PCDH11X ASTN1 CDH10	2.91e-04	427	106	9	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_200	ASH1L ZC3H11A EIF4G1 EPB41L2	2.96e-04	64	106	4	gudmap_developingGonad_e18.5_epididymis_200_k5
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX MAP4 ASH1L ZC3H11A EIF4G1 PLEC EPB41L2	3.23e-04	259	106	7	gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000	ABCA2 ABI3BP FAT3 APC2 LDHB ITPR1 AFAP1L2 OXCT1 CSPG4 PCDH11X ASTN1 NR3C2 CDH8 FRMD3	3.38e-04	972	106	14	Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305	KLHL24 ATRX ABI3BP MAP1B ASH1L PCDH11X PAK3	3.80e-04	266	106	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	TPR ABCA2 ATRX MAP1B MAP2 FAT3 APC2 LDHB PAPOLG ALMS1 PCDH11X PAK3 MACF1 ASTN1	3.90e-04	986	106	14	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	ABCA2 ATRX MAP1B MAP2 FAT3 APC2 RTN3 EZH2 OXCT1 ALMS1 PCDH11X PAK3 ASTN1 CDH8	4.02e-04	989	106	14	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	kidney_e13.5_Podocyte_MafB_top-relative-expression-ranked_100	FAT3 VCAN RAI2 FOXC2	4.18e-04	70	106	4	gudmap_kidney_e13.5_Podocyte_MafB_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	APC2 EZH2 OXCT1 ALMS1 MACF1 ASTN1 CDH8	4.24e-04	271	106	7	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	GPHN MAP1B FAT3 PAPOLG OXCT1 ALMS1 EIF5B PAK3 ASTN1 ELF1 CDH8	4.27e-04	654	106	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	TPR ABCA2 TCF12 ATRX MAP1B MAP2 FAT3 PARP3 RTN3 EZH2 SHROOM2 TRIM24 PAPOLG ALMS1 PAK3 ASTN1 TP53BP1	4.32e-04	1370	106	17	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000	TCF12 PARP3 IRAG1 VCAN PCDH11X EPB41L2	4.43e-04	195	106	6	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2	MAP1B MAP2 APC2 OXCT1 PAK3 ASTN1 CDH8	5.05e-04	279	106	7	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000	MAP4 ASH1L ZC3H11A ARHGAP31 EIF4G1 PCDH11X EPB41L2	5.61e-04	284	106	7	gudmap_developingGonad_e16.5_epididymis_1000_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#5_top-relative-expression-ranked_1000	ABI3BP PARP3 AHNAK TNXB AHNAK2	6.04e-04	136	106	5	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	TPR ABCA2 TCF12 ATRX MAP1B MAP2 FAT3 IRAG1 EZH2 TRIM24 PAPOLG URB1 ALMS1 PAK3 MACF1 ASTN1 TP53BP1	6.18e-04	1414	106	17	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#2_top-relative-expression-ranked_1000	MAP1B MAP4 PCDH11X ASTN1 CDH10	6.46e-04	138	106	5	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k2_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100	MAP1B VCAN PCDH11X	6.46e-04	34	106	3	gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4	MAP1B FAT3 PAPOLG PAK3 ASTN1	6.67e-04	139	106	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_100	MYOM1 MAP1B VCAN PCDH11X	7.96e-04	83	106	4	gudmap_developingLowerUrinaryTract_e14.5_ bladder_100
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100	ATRX ZC3H11A EIF4G1 EPB41L2	8.33e-04	84	106	4	gudmap_developingGonad_e14.5_ epididymis_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	ABCA2 MAP1B MAP2 FAT3 APC2 PAPOLG PCDH11X PAK3 ASTN1	8.53e-04	496	106	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	TPR TCF12 ATRX MAP1B MAP2 EZH2 TRIM24 PAPOLG OXCT1 ALMS1 SBNO1 EIF5B PAK3 MACF1 ASTN1 TOPORS TP53BP1	8.78e-04	1459	106	17	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#2_top-relative-expression-ranked_1000	ABI3BP PARP3 LAMA3 AHNAK AHNAK2	8.85e-04	148	106	5	gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	ILF3 MAP1B RTN3 PAK3 CDH8 TP53BP1	9.36e-04	225	106	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	ATRX MAP4 ASH1L TRIM24 ZC3H11A EIF4G1 PAK3 EPB41L2	9.39e-04	403	106	8	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	TPR ILF3 ACACA MAP1B FAT3 VCAN PCDH11X	9.74e-04	312	106	7	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500	TPR ILF3 MAP1B FAT3 VCAN PCDH11X ASTN1 CDH10	1.00e-03	407	106	8	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlas	gudmap_RNAseq_p2_CD2APMEISWT_2500_K4	KLHL24 MYOM1 PARP3 IRAG1 ITPR1 LPIN1 AFAP1L2 AHNAK CSPG4 NR3C2 PLEC FRMD3	1.01e-03	842	106	12	gudmap_RNAseq_p2_CD2APMEISWT_2500_K4
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500	ATRX ASH1L TRIM24 ZC3H11A EIF4G1 PCDH11X CDH10 EPB41L2	1.03e-03	409	106	8	gudmap_developingGonad_e12.5_ovary_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000	TPR ABCA2 ABI3BP FAT3 APC2 LDHB AFAP1L2 OXCT1 CSPG4 PCDH11X ASTN1 CDH8 FRMD3	1.05e-03	967	106	13	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000	ABCA2 ABI3BP FAT3 APC2 LDHB AFAP1L2 OXCT1 CSPG4 PCDH11X ASTN1 NR3C2 CDH8 FRMD3	1.05e-03	967	106	13	Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	MAP1B FAT3 RTN3 PAK3 ASTN1 CDH8	1.07e-03	231	106	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	ATRX MAP4 FAT3 ASH1L ZC3H11A EIF4G1 PCDH11X EPB41L2	1.10e-03	413	106	8	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000	MYOM1 ABI3BP MAP1B MAP4 PARP3 IRAG1 AHNAK PIP NR3C2 TNXB AHNAK2	1.10e-03	734	106	11	gudmap_developingLowerUrinaryTract_adult_bladder_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#1	ABCA2 FAT3 APC2 OXCT1 ASTN1 CDH8	1.12e-03	233	106	6	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	ABCA2 ABI3BP APC2 LDHB AFAP1L2 OXCT1 CSPG4 PCDH11X PAK3 ASTN1 DDX21 CDH8 FRMD3	1.15e-03	976	106	13	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500	ATRX MAP1B ASH1L TRIM24 ZC3H11A EIF4G1 PCDH11X CDH10	1.17e-03	417	106	8	gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	ATRX ASH1L TRIM24 ZC3H11A EIF4G1 PCDH11X EPB41L2	1.19e-03	323	106	7	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200	ATRX ASH1L ZC3H11A EIF4G1 EPB41L2	1.22e-03	159	106	5	gudmap_developingGonad_e12.5_epididymis_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	ABI3BP MAP1B MAP2 APC2 AFAP1L2 OXCT1 CSPG4 PCDH11X PAK3 MACF1 ASTN1 CDH8 FRMD3	1.23e-03	984	106	13	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000	KLHL24 MYOM1 PARP3 IRAG1 ITPR1 LIFR AFAP1L2 ARHGAP31 AHNAK RSBN1L EPB41L2 FRMD3	1.36e-03	872	106	12	gudmap_kidney_adult_Mesangium_Meis_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_500	MAP1B MAP4 PCDH11X CDH10	1.37e-03	96	106	4	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k1
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_200	MYOM1 MAP1B IRAG1 VCAN EPB41L2	1.40e-03	164	106	5	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_200
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR ATRX ASH1L AHNAK TCF25 MACF1 DDX21 DYNC1H1 GOLGB1 SON	5.81e-11	200	107	10	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ASH1L LDHB TRIP11 EIF5B ELF1 DDX21 GOLGB1 SON	7.70e-10	187	107	9	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TPR KLHL24 ATRX MAP1B TRIP11 ZC3H11A SBNO1 EIF5B GOLGB1	1.33e-09	199	107	9	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL5A1 ABI3BP LIFR GTF3C1 VCAN MACF1 TNXB CDH10 EPB41L2	1.39e-09	200	107	9	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX TRIP11 USP8 AHNAK MACF1 ELF1 DDX21	1.55e-08	184	107	8	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX MAP1B ASH1L SBNO1 EIF5B ELF1 SON	1.83e-08	188	107	8	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATRX MAP1B MAP4 AHNAK MACF1 GOLGB1 EPB41L2 SON	1.99e-08	190	107	8	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR COL5A1 ATRX ASH1L TRIP11 ARHGAP31 MACF1 SON	2.34e-08	194	107	8	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX MAP1B ASH1L TRIP11 MACF1 DYNC1H1 GOLGB1 SON	2.44e-08	195	107	8	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL5A1 MAP1B AHNAK VCAN SVIL ASTN1 TNXB EPB41L2	2.64e-08	197	107	8	2744cc94883c5d0424677cf5093bbab622933e9b
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL5A1 MAP1B LIFR AHNAK VCAN SVIL ASTN1 EPB41L2	2.85e-08	199	107	8	9846d6a31635fde759d55674631c11ab9270a603
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ILF3 AHNAK MACF1 ELF1 DDX21 DYNC1H1 GOLGB1 SON	2.96e-08	200	107	8	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ASH1L TRIP11 TCF25 MACF1 ELF1 DDX21	2.93e-07	182	107	7	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 MAP1B MAP2 IRAG1 CSPG4 EPB41L2 FRMD3	3.27e-07	185	107	7	7092436b4db90289516ed130ade596e3021cffaf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 MAP1B MAP2 IRAG1 CSPG4 EPB41L2 FRMD3	3.27e-07	185	107	7	a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX TRIP11 USP8 AHNAK MACF1 ELF1	3.27e-07	185	107	7	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	COL5A1 MAP1B MAP2 FAT3 IRAG1 ITPR1 FRMD3	3.39e-07	186	107	7	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMA3 AHNAK VCAN TCF25 ASTN1 PLEC DDX21	3.39e-07	186	107	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	MAP2 FAT3 LAMA3 IRAG1 ITPR1 SVIL MACF1	3.65e-07	188	107	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MAP1B FAT3 IRAG1 VCAN CSPG4 EPB41L2	3.91e-07	190	107	7	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	facs-Heart-LV-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A1 MAP2 ITPR1 AFAP1L2 VCAN CSPG4 TNXB	4.06e-07	191	107	7	b7a57691a4742070cee640e285c1f4d0da95baf1
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX ABI3BP MAP1B TRIP11 CPQ VCAN TNXB	4.06e-07	191	107	7	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	COL5A1 ABI3BP ITPR1 VCAN TNXB EPB41L2 FRMD3	4.20e-07	192	107	7	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	LA\|World / Chamber and Cluster_Paper	CACNA1E ABI3BP MAP1B IRAG1 PCNX2 VCAN TNXB	4.35e-07	193	107	7	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MYOM1 MAP1B MAP2 IRAG1 VCAN CSPG4	4.50e-07	194	107	7	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX MAP1B ASH1L MACF1 DYNC1H1 GOLGB1 SON	4.66e-07	195	107	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MYOM1 MAP1B FAT3 IRAG1 SVIL EPB41L2	4.83e-07	196	107	7	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL5A1 ABI3BP FAT3 LIFR VCAN MACF1 EPB41L2	4.83e-07	196	107	7	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MYOM1 MAP1B FAT3 IRAG1 SVIL EPB41L2	4.83e-07	196	107	7	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	Mild\|World / Condition, Lineage, Cell class and cell subclass	TPR ATRX ADH5 MAGED2 SASH3 RSBN1L GOLGB1	5.00e-07	197	107	7	476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A1 ABI3BP MAP1B PERM1 VCAN PAK3 TNXB	5.00e-07	197	107	7	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B MAP2 ITPR1 PCDH11X PAK3 GOLGA8B CDH12	5.17e-07	198	107	7	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL5A1 ABI3BP FAT3 LIFR VCAN MACF1 EPB41L2	5.17e-07	198	107	7	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	background-Hepatic_Stellate_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	COL5A1 ABI3BP MAP1B MAP2 FAT3 LIFR TNXB	5.17e-07	198	107	7	bd11b0e9e80449aab979a02c1023e0638c431c7c
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ATRX ASH1L LPIN1 TCF25 GOLGA8B MACF1 GOLGB1	5.35e-07	199	107	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL5A1 ABI3BP ADH5 VCAN MACF1 TNXB FRMD3	5.35e-07	199	107	7	c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	COL5A1 ABI3BP LIFR VCAN MACF1 TNXB CDH10	5.35e-07	199	107	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TPR ATRX TRIP11 ZC3H11A SBNO1 EIF5B GOLGB1	5.35e-07	199	107	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL5A1 ABI3BP LIFR VCAN MACF1 TNXB EPB41L2	5.35e-07	199	107	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	(2)_Fibroblasts-(24)_Fibro-5\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	COL5A1 ABI3BP AHNAK VCAN PLEC TNXB AHNAK2	5.35e-07	199	107	7	6c0354f57883330c685a8d9d5d3014ace7eca584
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL5A1 ABI3BP MAP1B FAT3 VCAN TNXB EPB41L2	5.53e-07	200	107	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYOM1 MAP1B PERM1 IRAG1 ITPR1 CSPG4 FOXC2	5.53e-07	200	107	7	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL5A1 ABI3BP ADH5 LIFR VCAN MACF1 TNXB	5.53e-07	200	107	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABI3BP MAP1B MAP2 TIE1 ARHGAP31 TTLL2	3.06e-06	166	107	6	8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYOM1 MAP1B IRAG1 CSPG4 PAK3 TNXB	3.17e-06	167	107	6	784776d1fcc098f84d3c2eca58fa56cb9428f434
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MAP1B MAP2 IRAG1 EZH2 VCAN	3.63e-06	171	107	6	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MAP1B MAP2 IRAG1 EZH2 VCAN	3.63e-06	171	107	6	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX TRIP11 AHNAK MACF1 NR3C2	4.29e-06	176	107	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOM1 MAP1B MAP2 IRAG1 CSPG4 ASTN1	4.72e-06	179	107	6	8da6863edc756540bb097cc7221c1408640d9bb4
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	COL5A1 ABI3BP MAP2 LAMA3 VCAN PAK3	4.72e-06	179	107	6	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOM1 MAP1B MAP2 IRAG1 CSPG4 ASTN1	4.72e-06	179	107	6	f39c13c99a07d009cc677e363ffe089089c64916
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4 LDHB TIE1 AHNAK MACF1 EPB41L2	4.88e-06	180	107	6	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP4 LDHB TIE1 AHNAK MACF1 EPB41L2	4.88e-06	180	107	6	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPHN ABI3BP MAP1B LAMA3 FRMD3 FOXC2	5.03e-06	181	107	6	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX TRIP11 USP8 AHNAK MACF1	5.20e-06	182	107	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL5A1 ABI3BP MAP1B TNXB EPB41L2 FRMD3	5.20e-06	182	107	6	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B LAMA3 AFAP1L2 TIE1 FRMD3 FOXC2	5.36e-06	183	107	6	12e876d6205af8aad74265c668b5e95b9e7487f3
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP FAT3 IRAG1 PAK3 TNXB FOXC2	5.36e-06	183	107	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	droplet-Lung-nan-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABI3BP MAP1B AFAP1L2 TIE1 MAGED2 FOXC2	5.71e-06	185	107	6	eeb6f55a6f79adf80247baa2c4b0df44553557ad
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B LAMA3 KIAA1671 TIE1 FRMD3 FOXC2	5.89e-06	186	107	6	1e67bfb248366d7395efdd2d5e70a97bdb2e68af
ToppCell	droplet-Spleen-nan-3m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX TRIP11 FAM78A MACF1 ELF1	5.89e-06	186	107	6	26f1e9930adf2fe4af0819e56f69915bd8330e4a
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TPR KLHL24 ATRX IRAG1 USP8 ALMS1	5.89e-06	186	107	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL5A1 MAP1B IRAG1 CSPG4 EPB41L2 FRMD3	5.89e-06	186	107	6	0c477016c1b539b3086a8066c3c6443f08c222a3
ToppCell	3'-Adult-Appendix-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABI3BP MAP2 ITPR1 LIFR ARHGAP31 AHNAK2	6.07e-06	187	107	6	37d8ee5c8bd6324749e5a2adef1d0482c75da80c
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3BP MAP1B AFAP1L2 TIE1 FRMD3 FOXC2	6.07e-06	187	107	6	12129e02638c20d9b7c1c6e512d48bfd966e1029
ToppCell	3'-Adult-Appendix-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABI3BP MAP2 ITPR1 LIFR ARHGAP31 AHNAK2	6.07e-06	187	107	6	ec98d5e480b08854dfd0ba6b1dc6610455f90640
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABI3BP MAP1B AFAP1L2 TIE1 FRMD3 FOXC2	6.07e-06	187	107	6	83930ef55191eff9006113feaeabb3c2fa21fd05
ToppCell	P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ABI3BP MAP1B KIAA1671 TIE1 ARHGAP31 FRMD3	6.07e-06	187	107	6	66ebe1788d51b3e17bec6cdb219f709756b4e530
ToppCell	E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MAP1B MAP2 AFAP1L2 MAGED2 CSPG4 FOXC2	6.07e-06	187	107	6	0dee138738b65531ff134a125b92234b5d0a653c
ToppCell	Pericytes-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	COL5A1 MAP1B IRAG1 CSPG4 CDH8 FOXC2	6.26e-06	188	107	6	f16ff998393bf1954bbf10caab15173bdb104ac1
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ASH1L ITPR1 MACF1 DYNC1H1 GOLGB1 TP53BP1	6.26e-06	188	107	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 MAP1B MAP2 IRAG1 CSPG4 ASTN1	6.45e-06	189	107	6	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYOM1 MAP1B MAP2 PERM1 IRAG1 CSPG4	6.45e-06	189	107	6	d69b7a01dd4d6ad043bb6210e9ab34b49578389c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 IRAG1 CSPG4 ASTN1 CDH8 FOXC2	6.45e-06	189	107	6	032f169e8ede653117919bf97c17f92043320b3c
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOM1 MAP1B IRAG1 CSPG4 HACL1 FOXC2	6.45e-06	189	107	6	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 MAP1B MAP2 IRAG1 CSPG4 ASTN1	6.45e-06	189	107	6	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 IRAG1 CSPG4 ASTN1 CDH8 FOXC2	6.45e-06	189	107	6	07208d32afca6f93207a2ac35b647b31a9f71b7c
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	MAP2 FAT3 LAMA3 IRAG1 ITPR1 MACF1	6.45e-06	189	107	6	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYOM1 MAP1B MAP2 PERM1 IRAG1 CSPG4	6.45e-06	189	107	6	2b5f1b4f173a224342ea4f10b193ee33b7662699
ToppCell	3'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYOM1 MAP1B MAP2 PERM1 IRAG1 CSPG4	6.45e-06	189	107	6	43e131458d8a4b120f7a5fb3d0c5650abded15f6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MAP1B IRAG1 SVIL PAK3 CDH8	6.65e-06	190	107	6	2e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MAP1B IRAG1 SVIL PAK3 CDH8	6.65e-06	190	107	6	0028f886c789ba238c031eae5d96acaed4af8c25
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL5A1 ABI3BP LIFR VCAN TNXB EPB41L2	6.65e-06	190	107	6	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYOM1 MAP1B IRAG1 MAGED2 CSPG4 TNXB	6.65e-06	190	107	6	140aca04c044cd7a93f81ff1631b00b5216d2cb1
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX ASH1L TRIP11 NR3C2 GOLGB1	6.85e-06	191	107	6	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABI3BP MAP2 KIAA1671 TIE1 ARHGAP31 PCDH11X	6.85e-06	191	107	6	b2c86cde341fe350143658c8a8a4a9edbce3f19b
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL5A1 MAGED2 VCAN TNXB AHNAK2 FOXC2	6.85e-06	191	107	6	db4943dd19207663fb9e27f8940fa4b06a933625
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MAP1B FAT3 IRAG1 VCAN EPB41L2	6.85e-06	191	107	6	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MAP1B FAT3 IRAG1 VCAN EPB41L2	6.85e-06	191	107	6	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B MAP2 IRAG1 CSPG4 EPB41L2 FOXC2	6.85e-06	191	107	6	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR ATRX ASH1L TRIP11 NR3C2 GOLGB1	6.85e-06	191	107	6	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B MAP2 IRAG1 CSPG4 EPB41L2 FOXC2	6.85e-06	191	107	6	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL5A1 ABI3BP CPQ VCAN TNXB EPB41L2	7.06e-06	192	107	6	321850b0f881420c2d57d3e825e365c82fa511ab
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MAP1B IRAG1 VCAN TNXB EPB41L2	7.06e-06	192	107	6	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	ILF3 ASH1L TCF25 EIF5B SON AHNAK2	7.06e-06	192	107	6	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL5A1 ABI3BP MAGED2 CPQ VCAN TNXB	7.06e-06	192	107	6	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A1 MAP2 SH3TC1 SVIL MACF1 DDX21	7.06e-06	192	107	6	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL5A1 ABI3BP CPQ VCAN TNXB EPB41L2	7.06e-06	192	107	6	cf2765d8bc074f7f9ee864eae632a3b705175842
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	COL5A1 ABI3BP PAK3 ASTN1 TNXB EPB41L2	7.06e-06	192	107	6	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOM1 MAP1B MAP2 IRAG1 CSPG4 ASTN1	7.27e-06	193	107	6	1043b28503bfaa0d5a82ec358bc86cbde73ea8f2
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ATRX AHNAK MACF1 DYNC1H1 GOLGB1	3.15e-05	49	81	5	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ATRX EIF5B GOLGB1 SON	4.90e-04	49	81	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED
Computational	Genes upregulated in subsets of cells of a given type within various tumors	KLHL24 MAP2 VCAN GOLGB1	5.30e-04	50	81	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ASH1L TRIP11 MACF1 GOLGB1	5.30e-04	50	81	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ASH1L MACF1 DYNC1H1 GOLGB1	5.30e-04	50	81	4	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Drug	torcetrapib	TPR KLHL24 ILF3 EP400 ATRX MAP4 PAPOLG EIF4G1 ELF1 NR3C2 DYNC1H1 TP53BP1	7.52e-08	342	107	12	ctd:C483909
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	TPR KLHL24 ILF3 ABI3BP MAP1B MAP4 ALMS1 TCF25 ELF1	3.43e-07	194	107	9	4312_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	COL5A1 KLHL24 ABCA2 MAP1B MAP4 AHDC1 ALMS1 SVIL MACF1	3.91e-07	197	107	9	6011_DN
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	GPHN SHROOM2 ITPR1 SVIL YLPM1 MACF1 NR3C2 SON	1.93e-06	177	107	8	4652_DN
Drug	deoxynivalenol	EP400 ATRX MAP4 EZH2 ZC3H11A AHNAK EIF4G1 EIF5B PLEC DDX21 BCL2L13 EPB41L2	2.78e-06	481	107	12	ctd:C007262
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	TPR ILF3 MAP4 YLPM1 TCF25 ELF1 PLEC SON	2.90e-06	187	107	8	4302_DN
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	TPR KLHL24 ILF3 ATRX MAP4 LPIN1 ALMS1 ELF1	3.02e-06	188	107	8	4545_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	TPR KLHL24 ABI3BP MAP1B MAP4 ALMS1 TCF25 ELF1	3.27e-06	190	107	8	4306_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A	ACACA MAP4 ALMS1 MAGED2 SVIL YLPM1 TOPORS SON	4.78e-06	200	107	8	2027_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	KLHL24 MAP1B MAP2 ITPR1 LPIN1 RAI2 AHNAK2	2.07e-05	177	107	7	4710_UP
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	KLHL24 MAP1B MAP2 URB1 AHNAK RAI2 AHNAK2	2.22e-05	179	107	7	5903_UP
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	KLHL24 ATRX ABI3BP MAP4 NR3C2 PLEC EPB41L2	2.56e-05	183	107	7	7088_DN
Drug	CP-690334-01 [459212-38-5]; Up 200; 10uM; MCF7; HT_HG-U133A	KLHL24 MAP2 APC2 ITPR1 LPIN1 RAI2 AHNAK2	2.84e-05	186	107	7	4380_UP
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	TPR KLHL24 MAP1B MAP4 SBNO1 TCF25 ELF1	3.15e-05	189	107	7	4304_DN
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A	TPR KLHL24 ILF3 MAP1B MAP4 SBNO1 TCF25	3.26e-05	190	107	7	4307_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	TPR ILF3 ATRX MAP1B MAP4 TCF25 ELF1	3.37e-05	191	107	7	4303_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ATRX ABI3BP MAP4 ASH1L LAMA3 YLPM1 EIF4G1	3.37e-05	191	107	7	6020_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	MAP4 RHOT2 TRIP11 PAPOLG URB1 INTS5 AHNAK	3.37e-05	191	107	7	2937_DN
Drug	Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A	KLHL24 MAP1B LAMA3 TMCO6 ALMS1 YLPM1 EPB41L2	3.37e-05	191	107	7	7435_DN
Drug	Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; PC3; HT_HG-U133A	KLHL24 PAPOLG CPQ SBNO1 TCF25 EIF5B ELF1	3.48e-05	192	107	7	4267_DN
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; HL60; HT_HG-U133A	RALGAPB PCNX2 ALMS1 MAGED2 CPQ VCAN MACF1	3.60e-05	193	107	7	2366_DN
Drug	AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A	KLHL24 ILF3 TMCO6 TRIM24 ITPR1 ALMS1 EIF4G1	3.60e-05	193	107	7	6920_UP
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A	GPHN TPR RHOT2 LPIN1 ALMS1 MAGED2 VCAN	3.72e-05	194	107	7	1856_DN
Drug	Famprofazone [22881-35-2]; Down 200; 10.6uM; PC3; HT_HG-U133A	TPR ATRX ABI3BP MAP4 TMCO6 SBNO1 EIF5B	3.72e-05	194	107	7	4309_DN
Drug	Dipyridamole [58-32-2]; Down 200; 8uM; HL60; HG-U133A	ACACA EP400 MAP4 ITPR1 EIF5B EPB41L2 SON	3.84e-05	195	107	7	2017_DN
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	TPR KLHL24 ILF3 TMCO6 ITPR1 ALMS1 EIF4G1	3.84e-05	195	107	7	6918_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	KLHL24 ASH1L LAMA3 TMCO6 AHNAK YLPM1 GOLGB1	3.84e-05	195	107	7	1045_UP
Drug	Flufenamic acid [530-78-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	ABCA2 MYOM1 APC2 ITPR1 SASH3 VCAN PIP	4.10e-05	197	107	7	2267_UP
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	ATRX MAP4 ASH1L RHOT2 ITPR1 SH3TC1 PAK3	4.10e-05	197	107	7	3750_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	TPR MAP4 RHOT2 LPIN1 VCAN YLPM1 NR3C2	4.10e-05	197	107	7	5746_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; HL60; HG-U133A	ABCA2 RHOT2 EZH2 ITPR1 AHNAK TOPORS SON	4.23e-05	198	107	7	2002_UP
Drug	Thalidomide [50-35-1]; Down 200; 15.4uM; HL60; HG-U133A	TPR RHOT2 ITPR1 ALMS1 AHNAK TOPORS EPB41L2	4.23e-05	198	107	7	1411_DN
Drug	Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; HL60; HG-U133A	KLHL24 ACACA RALGAPB ITPR1 ALMS1 SBNO1 MACF1	4.51e-05	200	107	7	1389_DN
Drug	forskolin; Up 200; 50uM; MCF7; HT_HG-U133A_EA	KLHL24 LAMA3 ITPR1 SVIL YLPM1 TCF25	9.95e-05	157	107	6	913_UP
Drug	valerate	TCF12 MAP4 ADH5 OXCT1 TOPORS	1.21e-04	102	107	5	CID000007991
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A	KLHL24 MAP1B MAP2 ITPR1 RAI2 AHNAK2	1.64e-04	172	107	6	5217_UP
Drug	AC1O3R26	ACACA HACL1 TNXB	1.67e-04	23	107	3	CID006335053
Drug	Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	KLHL24 MAP1B ITPR1 LPIN1 RAI2 AHNAK2	1.86e-04	176	107	6	992_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	KLHL24 MAP1B MAP4 LPIN1 RAI2 AHNAK2	1.86e-04	176	107	6	6972_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	KLHL24 MAP1B ITPR1 LPIN1 RAI2 AHNAK2	1.97e-04	178	107	6	5693_UP
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	TPR ILF3 MAP4 EIF4G1 ELF1 SON	1.97e-04	178	107	6	3998_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	TPR ILF3 MAP4 EIF4G1 ELF1 SON	2.03e-04	179	107	6	4585_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	SHROOM2 ITPR1 LPIN1 LIFR RAI2 AHNAK2	2.03e-04	179	107	6	4184_UP
Drug	Gossypol [303-45-7]; Up 200; 7.8uM; MCF7; HT_HG-U133A	KLHL24 MAP1B PARP3 LPIN1 SH3TC1 BCL2L13	2.03e-04	179	107	6	4762_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	KLHL24 MAP4 ITPR1 LPIN1 RAI2 AHNAK2	2.16e-04	181	107	6	7453_UP
Drug	sulfometuron	ACACA ALMS1	2.17e-04	5	107	2	CID000052998
Drug	monoacetoacetin	ACACA OXCT1	2.17e-04	5	107	2	CID000125624
Drug	3-hydroxy-3-methylglutaric acid	LIFR OXCT1 CSPG4 PLEC	2.22e-04	63	107	4	CID000001662
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	KLHL24 MAP1B MAP2 ITPR1 RAI2 AHNAK2	2.29e-04	183	107	6	6434_UP
Drug	Metergoline [17692-51-2]; Up 200; 10uM; MCF7; HT_HG-U133A	COL5A1 KLHL24 LDHB PAPOLG LPIN1 RAI2	2.29e-04	183	107	6	3221_UP
Drug	Nevirapine	SLC34A2 TRIM24 ITPR1 LPIN1 LIFR	2.30e-04	117	107	5	ctd:D019829
Drug	Forskolin, from Coleus forskohlii; Up 200; 0.5uM; MCF7; HT_HG-U133A	ABCA2 MAP4 TMCO6 AHDC1 ITPR1 SVIL	2.43e-04	185	107	6	7055_UP
Drug	Retinoic acid [302-79-4]; Down 200; 13.4uM; HL60; HG-U133A	EP400 MAP4 RHOT2 URB1 EIF5B DDX21	2.50e-04	186	107	6	1548_DN
Drug	Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	COL5A1 KLHL24 MAP4 ITPR1 LPIN1 CPQ	2.58e-04	187	107	6	5438_UP
Drug	rosiglitazone; Down 200; 10uM; PC3; HT_HG-U133A	COL5A1 KLHL24 ABI3BP SHROOM2 TRIP11 PAK3	2.58e-04	187	107	6	4457_DN
Drug	Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; HL60; HG-U133A	ACACA EP400 MAP4 RHOT2 ELF1 DDX21	2.65e-04	188	107	6	1622_DN
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	ILF3 MAP4 CDC40 EIF4G1 ELF1 SON	2.65e-04	188	107	6	6735_DN
Drug	Benzethonium chloride [121-54-0]; Down 200; 9uM; HL60; HT_HG-U133A	ABCA2 MAP4 URB1 ALMS1 CDH8 CDH10	2.73e-04	189	107	6	2508_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A	COL5A1 TMCO6 PCNX2 ALMS1 SH3TC1 PAK3	2.73e-04	189	107	6	3733_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	ILF3 ATRX TMCO6 VCAN ELF1 RAI2	2.73e-04	189	107	6	6649_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	PCNX2 LPIN1 GTF3C1 MACF1 EPB41L2 TP53BP1	2.81e-04	190	107	6	1421_UP
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	TPR MAP4 PARP3 VCAN EIF4G1 ELF1	2.89e-04	191	107	6	6644_DN
Drug	MAPS	MAP1B MAP2 MAP4 TRIP11 PLEC DYNC1H1	2.89e-04	191	107	6	CID000066161
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	TPR MAP1B MAP4 CDC40 YLPM1 TCF25	2.89e-04	191	107	6	4273_DN
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A	TPR ATRX MAP4 CPQ TCF25 ELF1	2.89e-04	191	107	6	3926_DN
Drug	GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A	KLHL24 TMCO6 SHROOM2 ITPR1 YLPM1 EPB41L2	2.97e-04	192	107	6	7106_DN
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A	TPR MAP4 SBNO1 TCF25 ELF1 PLEC	2.97e-04	192	107	6	4268_DN
Drug	Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A	COL5A1 LPIN1 SH3TC1 PIP SVIL AHNAK2	2.97e-04	192	107	6	4129_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A	TPR KLHL24 MAP1B MAP4 SBNO1 ELF1	2.97e-04	192	107	6	4311_DN
Drug	Ergocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A	PARP3 URB1 MAGED2 CPQ SH3TC1 PLEC	2.97e-04	192	107	6	2572_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	MAP4 RHOT2 GMIP ALMS1 TCF25 EIF5B	2.97e-04	192	107	6	1971_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A	KLHL24 ABCA2 MAP4 TRIP11 ITPR1 SH3TC1	3.05e-04	193	107	6	3378_DN
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A	TPR MAP1B MAP4 YLPM1 TCF25 ELF1	3.05e-04	193	107	6	4305_DN
Drug	Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A	KLHL24 MAP4 TRIP11 AHDC1 YLPM1 PLEC	3.14e-04	194	107	6	1707_DN
Drug	5213008; Up 200; 18uM; MCF7; HT_HG-U133A_EA	COL5A1 KLHL24 MAP4 ITPR1 LPIN1 EIF5B	3.14e-04	194	107	6	898_UP
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	TPR COL5A1 MAP1B SBNO1 EIF5B ELF1	3.14e-04	194	107	6	4308_DN
Drug	catechin; Up 200; 11uM; MCF7; HT_HG-U133A_EA	ILF3 TMCO6 URB1 CDC40 SVIL PLEC	3.14e-04	194	107	6	1101_UP
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A	COL5A1 ABCA2 MAP4 LPIN1 INTS5 TOPORS	3.14e-04	194	107	6	2213_DN
Drug	SB 202190; Down 200; 1uM; PC3; HT_HG-U133A	TPR ATRX MAP2 MAP4 TRIP11 VCAN	3.22e-04	195	107	6	7058_DN
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	KLHL24 MAP4 SLC34A2 PCNX2 LPIN1 PIP	3.22e-04	195	107	6	5265_UP
Drug	SC-560; Up 200; 10uM; MCF7; HT_HG-U133A	KLHL24 TCF12 MAP4 LAMA3 YLPM1 EIF5B	3.22e-04	195	107	6	6913_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A	KLHL24 ATRX RALGAPB TRIP11 AHDC1 PCNX2	3.22e-04	195	107	6	1184_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A	RALGAPB TMCO6 PCNX2 MAGED2 YLPM1 GOLGB1	3.22e-04	195	107	6	1785_UP
Drug	Metrizamide [31112-62-6]; Up 200; 5uM; HL60; HT_HG-U133A	TPR KLHL24 MAP4 SVIL PLEC EPB41L2	3.22e-04	195	107	6	1318_UP
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A	KLHL24 ATRX GMIP ALMS1 MAGED2 AHNAK	3.22e-04	195	107	6	6971_DN
Drug	colchicine; Down 200; 1uM; SKMEL5; HG-U133A	ILF3 ASH1L CDC40 VCAN EIF5B AHNAK2	3.22e-04	195	107	6	630_DN
Drug	Dronabinol	TPR ABCA2 ATRX MAP1B MAP2 RTN3 ZFPM1 SHROOM2 LDHB PAPOLG EIF4G1 PAK3 GOLGB1	3.26e-04	905	107	13	ctd:D013759
Drug	6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; HL60; HT_HG-U133A	TRIP11 LPIN1 INTS5 MACF1 TOPORS EPB41L2	3.31e-04	196	107	6	2511_DN
Drug	Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; PC3; HG-U133A	ALMS1 VCAN EIF5B MACF1 GOLGB1 SON	3.31e-04	196	107	6	1948_DN
Drug	Quinic acid [86-68-0]; Down 200; 19.6uM; HL60; HT_HG-U133A	PAPOLG URB1 INTS5 AHNAK VCAN MACF1	3.31e-04	196	107	6	2978_DN
Drug	Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A	COL5A1 ABCA2 MAP4 AHDC1 LPIN1 PIP	3.31e-04	196	107	6	5320_UP
Drug	Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A	MAP1B MAP4 ASH1L LPIN1 PLEC RAI2	3.31e-04	196	107	6	5338_UP
Drug	Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; HL60; HG-U133A	TPR ABCA2 MAP4 RHOT2 EIF5B TOPORS	3.31e-04	196	107	6	1586_UP
Drug	Sulpiride [15676-16-1]; Up 200; 11.8uM; PC3; HG-U133A	KLHL24 RHOT2 ITPR1 YLPM1 PAK3 TOPORS	3.40e-04	197	107	6	1887_UP
Drug	Methiazole; Down 200; 15uM; PC3; HT_HG-U133A	MAP4 PARP3 AHDC1 LPIN1 EIF4G1 MACF1	3.40e-04	197	107	6	4532_DN
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; PC3; HT_HG-U133A	MAP4 ASH1L TRIM24 URB1 CPQ SVIL	3.40e-04	197	107	6	7276_DN
Drug	0316684-0000 [391209-55-5]; Up 200; 10uM; MCF7; HT_HG-U133A	COL5A1 ABCA2 MAP4 GMIP AHDC1 PAPOLG	3.40e-04	197	107	6	7052_UP
Drug	Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; HL60; HG-U133A	TPR RALGAPB LPIN1 SBNO1 VCAN YLPM1	3.40e-04	197	107	6	1789_UP
Drug	Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	COL5A1 TRIP11 ITPR1 LPIN1 VCAN AHNAK2	3.40e-04	197	107	6	4818_UP
Drug	Neostigmine bromide [114-80-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	ABCA2 MAP4 LAMA3 TRIP11 ITPR1 LPIN1	3.40e-04	197	107	6	5335_UP
Disease	Malignant neoplasm of breast	LAMTOR5 APC2 EZH2 SHROOM2 LDHB FSCB ZC3H11A MAGED2 SBNO1 ANKRD30A MACF1 CDH10 GOLGB1 TP53BP1	2.77e-05	1074	105	14	C0006142
Disease	2-hydroxyoctanoate measurement	ALMS1 HACL1	1.25e-04	5	105	2	EFO_0800192
Disease	Colorectal Carcinoma	ACACA MAP1B MAP2 APC2 LPIN1 LIFR SH3TC1 EIF4G1 PCDH11X NR3C2	2.06e-04	702	105	10	C0009402
Disease	epidermolysis bullosa simplex (is_implicated_in)	KLHL24 PLEC	2.60e-04	7	105	2	DOID:4644 (is_implicated_in)
Disease	2-aminooctanoate measurement	ALMS1 HACL1	3.46e-04	8	105	2	EFO_0800349
Disease	Alcoholic Intoxication, Chronic	GPHN ADH5 ASTN1 CDH8 CDH10 CDH12	4.03e-04	268	105	6	C0001973
Disease	Ehlers-Danlos syndrome (is_implicated_in)	COL5A1 TNXB	4.44e-04	9	105	2	DOID:13359 (is_implicated_in)
Disease	2-ketocaprylate measurement	ALMS1 HACL1	5.54e-04	10	105	2	EFO_0800110
Disease	brain connectivity measurement	MAP2 FAT3 VCAN TCF25 LRRC8A PLEC FOXC2	5.82e-04	400	105	7	EFO_0005210
Disease	N-acetyl-2-aminooctanoate measurement	ALMS1 HACL1	8.09e-04	12	105	2	EFO_0800567
Disease	Intellectual Disability	CACNA1E MAP1B APC2 ASH1L MACF1 ASTN1 DYNC1H1	1.11e-03	447	105	7	C3714756
Disease	serum albumin measurement	MAP4 ZFPM1 ADH5 SBNO1 MACF1 PLEC RSBN1L TP53BP1	1.27e-03	592	105	8	EFO_0004535
Disease	N-acetylmethionine measurement	ITPR1 ALMS1	1.28e-03	15	105	2	EFO_0021427
Disease	Cardiovascular Abnormalities	APC2 FOXC2	1.46e-03	16	105	2	C0243050
Disease	focal segmental glomerulosclerosis	ALMS1 CDH12	1.46e-03	16	105	2	EFO_0004236
Disease	lower body strength measurement	PCNX2 KIAA1671	1.46e-03	16	105	2	EFO_0007999
Disease	Trigonocephaly	TCF12 EZH2	1.46e-03	16	105	2	C0265535
Disease	Scaphycephaly	TCF12 EZH2	1.46e-03	16	105	2	C0265534
Disease	Synostotic Posterior Plagiocephaly	TCF12 EZH2	1.46e-03	16	105	2	C1833340
Disease	Synostotic Anterior Plagiocephaly	TCF12 EZH2	1.46e-03	16	105	2	C2931150
Disease	Metopic synostosis	TCF12 EZH2	1.46e-03	16	105	2	C1860819
Disease	Craniosynostosis, Type 1	TCF12 EZH2	1.46e-03	16	105	2	C4551902
Disease	Acrocephaly	TCF12 EZH2	1.46e-03	16	105	2	C0030044
Disease	Prostatic Neoplasms	COL5A1 RPN2 ASH1L EZH2 LDHB ITPR1 LIFR CDH12	1.63e-03	616	105	8	C0033578
Disease	Malignant neoplasm of prostate	COL5A1 RPN2 ASH1L EZH2 LDHB ITPR1 LIFR CDH12	1.63e-03	616	105	8	C0376358
Disease	Brachycephaly	TCF12 EZH2	1.65e-03	17	105	2	C0221356
Disease	diet measurement, HOMA-B	FAT3 PCNX2	2.06e-03	19	105	2	EFO_0004469, EFO_0008111
Disease	mean reticulocyte volume	EP400 ZFPM1 EZH2 USP8 GTF3C1 MAGED2 ELF1 GOLGB1 EPB41L2	2.23e-03	799	105	9	EFO_0010701
Disease	Craniosynostosis	TCF12 EZH2	2.29e-03	20	105	2	C0010278
Disease	white matter microstructure measurement	KLHL24 TMCO6 IRAG1 TIE1 VCAN PLEC	2.75e-03	390	105	6	EFO_0005674
Disease	ubiquitin carboxyl-terminal hydrolase 25 measurement	USP8 TNXB	2.77e-03	22	105	2	EFO_0021881
Disease	alkaline phosphatase measurement	MAP4 ZFPM1 ITPR1 ADH5 AHNAK MACF1 ELF1 NR3C2 GOLGB1 TP53BP1	3.36e-03	1015	105	10	EFO_0004533
Disease	phosphatidylcholine measurement	COL5A1 MACF1 TNXB DYNC1H1 FRMD3	3.52e-03	284	105	5	EFO_0010226

Protein segments in the cluster

Peptide	Gene	Start	Entry
KAATTEPTEVEEVVP	BCL2L13	386	Q9BXK5
PVKAEEFVVLSQEPS	EP400	2076	Q96L91
EKSIDAVIATASAPP	ASH1L	1731	Q9NR48
KDPVEVAQPSEVLRT	ELF1	356	P32519
VPKIPTACITVEDAE	CPQ	226	Q9Y646
LVTTVPKDPEAAEAR	VCAN	1416	P13611
QEAVPPADIVFSVKS	CSPG4	1266	Q6UVK1
TVAIPDVDPLVDSTV	CACNA1E	1071	Q15878
SIEEIEVAPPKAHEV	ADH5	21	P11766
VVADISVAKIDPLAP	ADH5	151	P11766
TEEALKVSPVSIPAE	ALMS1	1961	Q8TCU4
LTAAVEPTEEATPVA	AFAP1L2	511	Q8N4X5
ESLVEKTPDEAAPLV	ANKRD30A	296	Q9BXX3
KIIEEAPATIATPAV	ACACA	386	Q13085
PEVDVNLPKADVVVS	AHNAK	2066	Q09666
PKEPAVVAAEAATVA	AHDC1	561	Q5TGY3
DTPAEPVLLEVTKAA	ASTN1	961	O14525
AAKVIVSVEDAVPTI	RAI2	436	Q9Y5P3
APRDVTPEATKEVIE	GPHN	91	Q9NQX3
PSSIEAIPFVIEKAV	HACL1	141	Q9UJ83
VSEQEKTVEEVPHPL	PARP3	301	Q9Y6F1
RALSETVVEESDPKP	LRRC8A	171	Q8IWT6
VVESIASPAVPNKEV	PAK3	221	O75914
EVPFPKTEEVESAIS	NR3C2	371	P08235
IKVSAEAEVAPVSPE	MAP1B	1286	P46821
ATEVSKTPEAREAPA	MAGED2	66	Q9UNF1
AKNVVLPTETEVAPA	MAP4	331	P27816
LPTETEVAPAKDVTL	MAP4	336	P27816
DISEPEVAATVKVPE	LAMA3	1181	Q16787
EAISPAPEEKAVTLR	KIAA1671	746	Q9BY89
KVEPPTVEETLADVQ	FSCB	411	Q5H9T9
DKEAFAIVPVSPAEV	ITPR1	426	Q14643
PEEVPFVVTKCTAEI	GMIP	561	Q9P107
KVVEREEAVPEASPV	EPB41L2	786	O43491
SAPPLTEKEVENVFV	IRAG1	516	Q9Y6F6
VKESSIIAPAPAEDV	EZH2	471	Q15910
DTIVAKPVEEPADTS	PCNX2	316	A6NKB5
EEKVSAVSAEPPTTL	TCF12	651	Q99081
SIKVEAVEEPEAAPI	ZFPM1	461	Q8IX07
IEELKPPSASVVQTA	LPIN1	361	Q14693
VVIKSEAASPALPVI	FOXC2	211	Q99958
EAASPALPVITKVET	FOXC2	216	Q99958
HPVFKETEIEVSIPE	PCDH11X	246	Q9BZA7
VDVPSPDEKSVITYV	MACF1	276	Q9UPN3
NSAEPAAVIVEKPLS	PAPOLG	561	Q9BWT3
VVEASSKIQREPPEV	FRMD3	341	A2A2Y4
LLAVKSVPVDEDPET	APC2	241	O95996
IEIEDASPTKCPITT	ATRX	1521	P46100
EVAPLKEAVSSPAVT	KLHL24	436	Q6TFL4
VKISIEDVDEPPVFS	CDH10	371	Q9Y6N8
VLVKDTAVQTPDPAF	C19orf44	526	Q9H6X5
EVLKVSATDPDSEVP	FAT3	1901	Q8TDW7
TEAKPAVVAPAPVVE	ILF3	486	Q12906
PVSTKPVEDDVDVAS	ABCA2	2021	Q9BZC7
PVEAAKETTEVPEEL	COL5A1	296	P20908
EVEVTLSKPVPESEF	EIF4G1	326	Q04637
QAAKLTSDPTDIPVV	LAMTOR5	51	O43504
EVETHKVAAPDVVVP	DYNC1H1	2556	Q14204
KVAAPDVVVPTLDTV	DYNC1H1	2561	Q14204
EKLIAPVAEEEATVP	LDHB	6	P07195
VKISVLDVDEPPVFS	CDH12	371	P55289
ATVKIVVEDADEPPV	CDH8	376	P55286
TLTSAEKEPEAAVPA	GOLGA8B	396	A8MQT2
VDLVIQSSPPKDVES	DDX21	506	Q9NR30
QEPVAHTVSEPKVDI	SASH3	331	O75995
ETEAAVPVKQEPETV	SBNO1	56	A3KN83
AKLEVASSPPVSEAV	PERM1	421	Q5SV97
AFPKIEDTEIISPVA	LIFR	916	P42702
SLEDVSEVAPEKPIT	RTN3	591	O95197
VAAAAPTATVSEKEP	RSBN1L	11	Q6PCB5
TEEVVIAATEPIPAS	SVIL	741	O95425
IDVKASIDPVPTSID	FAM78A	41	Q5JUQ0
RAEEITIPADVTPEK	RHOT2	36	Q8IXI1
VIPASEEKAETPTAA	EIF5B	291	O60841
SKPSLAVAVDSAPEV	CDC40	46	O60508
STEERKEEPSVPAAV	SHROOM2	1376	Q13796
VSSEEVAVAAAPEPL	SH3TC1	261	Q8TE82
PVEAVKDIPDGATVL	OXCT1	46	P55809
APILSPEAAKAVAVT	INTS5	801	Q6P9B9
DIPKSVRPNDEVTAV	PIP	41	P12273
PHPVVVADLLKDSAV	URB1	2131	O60287
AAESPEAIIKEPIDI	SUCLA2	196	Q9P2R7
VDVSAPKVEADLSLP	AHNAK2	1021	Q8IVF2
VDVSAPKVEADVSLP	AHNAK2	1186	Q8IVF2
KDPKVEVTAPDVEVS	AHNAK2	1441	Q8IVF2
VDVSAPKVEADVSLP	AHNAK2	1516	Q8IVF2
VDVSEPKVEADVSLP	AHNAK2	1681	Q8IVF2
VDVSAPKVEAEVSLP	AHNAK2	1846	Q8IVF2
SIEASVDVPAPKVEA	AHNAK2	2006	Q8IVF2
SIEASVDVSPPKVEA	AHNAK2	2171	Q8IVF2
KDPKVEVTAPDVEVS	AHNAK2	2266	Q8IVF2
VDVSAPKVEAEVSLP	AHNAK2	3001	Q8IVF2
VDVSAPKVEADLSLP	AHNAK2	3166	Q8IVF2
VDVSAPKAEADVSLP	AHNAK2	3331	Q8IVF2
KVPKAEVTVPDVEVS	AHNAK2	3421	Q8IVF2
VDVSAPKVEADVSLP	AHNAK2	3661	Q8IVF2
KDPKVEVTAPDVEVS	AHNAK2	3916	Q8IVF2
VDVTAPKVEADVSLP	AHNAK2	3991	Q8IVF2
DVPVKAPETFDNITI	SLC34A2	656	O95436
SETDKEVLSPAVPAA	ZNF414	21	Q96IQ9
PVVIVKQESDEESRP	TRIM24	736	O15164
EEKEEPVAPELATTV	ZNF653	401	Q96CK0
VVIKFPEEEAPSTVL	RPN2	501	P04844
PVPVIESTEAIEAKA	TPR	656	P12270
IVEPEKTTAEFEVPR	TIE1	401	P35590
PLVSEDKSVTVPEAE	ZC3H11A	706	O75152
VHVEALTVPEEEKPS	TNXB	1961	P22105
AEEAPEKIIPSILAS	TMCO6	221	Q96DC7
VVEKAVSVRPEAAPA	TTLL2	471	Q9BWV7
EIVPFEKASPQATVE	ARHGAP31	756	Q2M1Z3
IPIAEQSSKDIPVTA	TP53BP1	226	Q12888
VVIVDVKEPSPRVDV	TP53BP1	756	Q12888
QARETFEKTPVEVPV	PLEC	3366	Q15149
DALTEIAFVVPSPVE	RALGAPB	1256	Q86X10
VVAKDTPEPVKEEVT	YLPM1	321	P49750
SVPEIAEVEPSKKVE	MAP2	1021	P11137
TAASQISEVKPVLPE	WASHC2A	971	Q641Q2
VIPARLPKTEVSAEE	nan	66	Q8N9G6
APSLEPFETKDVVTI	TOPORS	941	Q9NS56
PVADPKTLDSVTELA	TRIP11	881	Q15643
ERIETDIKQPTVPAS	ABI3BP	751	Q7Z7G0
EVISKTVPPVDIVFE	GTF3C1	351	Q12789
RVTEAPKHPISEELE	TOPBP1	1206	Q92547
VEPVAASKSDVSPII	USP8	381	P40818
LSEIKEAVAALPPDV	TCF25	561	Q9BQ70
DPSVLVSEAAVTVPE	SON	1236	P18583
DSVALVKETVVISPP	GOLGB1	1136	Q14789
SRVSEPVAALDPAEK	MYOM1	596	P52179